syndrome	score	normalized_score
MYOCLONIC EPILEPSY OF LAFORA	1.5181308	100.0
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	1.5	98.80571555494427
EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3	1.3055556	85.99757016984306
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	1.038238751	68.3892818062844
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	1.0311747820000001	67.92397479848246
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	1.000843882	65.92606394653214
227210 EYEBROWS, DUPLICATION OF, WITH STRETCHABLE SKIN AND SYNDACTYLY	1.0	65.87047703662951
HYPERTRICHOSIS UNIVERSALIS	1.0	65.87047703662951
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	1.0	65.87047703662951
EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	0.9484125999999999	62.47239038955009
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.6388886	42.083896855264385
#121200 SEIZURES, BENIGN FAMILIAL NEONATAL, 1; BFNS1EPILEPSY, BENIGN NEONATAL, 1, AND/OR MYOKYMIA, INCLUDED;;SEIZURES, BENIGN FAMILIAL NEONATAL, 1, AND/OR MYOKYMIA, INCLUDED	0.537771982	35.42329699127374
WITTEVEEN-KOLK SYNDROME	0.5221678329999999	34.39544425289309
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.519711782	34.23366300189681
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.5188679	34.178076091994186
EPILEPSY, BENIGN NEONATAL, 2	0.5147059	33.903923166567736
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.5143573819999999	33.88096611965187
#614265 COMBINED MALONIC AND METHYLMALONIC ACIDURIA; CMAMMA	0.500843882	32.99082542821738
VAN DEN ENDE-GUPTA SYNDROME; VDEGS	0.5	32.935238518314755
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.5	32.935238518314755
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.5	32.935238518314755
WILLIAMS-BEUREN SYNDROME; WBS	0.5	32.935238518314755
EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7	0.5	32.935238518314755
ROMBO SYNDROME	0.5	32.935238518314755
COMBINED SAPOSIN DEFICIENCY	0.5	32.935238518314755
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.48869108200000005	32.19031469488664
#300672 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 2; EIEE2;;INFANTILE SPASM SYNDROME, X-LINKED 2; ISSX2	0.475717633	31.335747420446246
#604403 GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 2; GEFSP2;;GEFS+, TYPE 2; GEFS+2FEBRILE SEIZURES, FAMILIAL, 3A, INCLUDED; FEB3A, INCLUDED	0.46636890000000003	30.71994191804817
CENTRALOPATHIC EPILEPSY	0.4484126	29.53715187123534
SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	0.44841259999999994	29.537151871235334
SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	0.44841259999999994	29.537151871235334
AICARDI SYNDROME; AIC	0.3964286	26.11294099296319
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.393990982	25.952373932470113
#602066 CONVULSIONS, FAMILIAL INFANTILE, WITH PAROXYSMAL CHOREOATHETOSIS;ICCA;;INFANTILE CONVULSIONS AND PAROXYSMAL CHOREOATHETOSIS, FAMILIAL;;ICCA SYNDROME;;PAROXYSMAL KINESIGENIC DYSKINESIA WITH INFANTILE CONVULSIONS; PKD/IC	0.3824787	25.19405442534991
#605751 SEIZURES, BENIGN FAMILIAL INFANTILE, 2; BFIS2;;CONVULSIONS, BENIGN FAMILIAL INFANTILE, 2; BFIC2	0.3824787	25.19405442534991
EPILEPSY WITH GRAND MAL SEIZURES ON AWAKENING	0.3752738	24.7194642253487
EPILEPSY, JUVENILE ABSENCE	0.3752738	24.7194642253487
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.3741988	24.648653462534323
CORNELIA DE LANGE SYNDROME 3	0.372295533	24.523284357316246
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.36256878200000003	23.882578628929735
EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2	0.3613516	23.802402269949336
#607682 EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 9; EIG9EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 6, INCLUDED; EJM6,INCLUDED	0.3596488	23.69023802165136
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIc; CDG2C	0.35639908200000003	23.476177546756844
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.353044782	23.255228205632875
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.349801882	23.04161683565079
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.3480389	22.925488370303796
TUBEROUS SCLEROSIS	0.346323951	22.81252386158031
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.3448273	22.713938746252957
CHROMOSOME 1P36 DELETION SYNDROME	0.338253933	22.28094792622612
THUMB AGENESIS, SHORT STATURE, AND IMMUNODEFICIENCY	0.333333	21.95680372205083
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A	0.333333	21.95680372205083
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.33074978200000005	21.786645920101222
#607208 DRAVET SYNDROME;;EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 6; EIEE6;;SEVERE MYOCLONIC EPILEPSY OF INFANCY; SMEI	0.31720818200000006	20.894654268262
#614202 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 15; MRT15	0.292668733	19.278229056415956
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.266468882	17.552432372757345
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.265549782	17.491890817312974
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.2647059	17.43630390741035
BOHRING-OPITZ SYNDROME	0.251759633	16.583527124276774
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.251759633	16.583527124276774
CHROMOSOME 16p13.3 DELETION SYNDROME	0.251759633	16.583527124276774
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.250915751	16.52794021437415
STURGE-WEBER SYNDROME	0.250915751	16.52794021437415
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.250915751	16.52794021437415
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.250843882	16.523206169060007
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.25	16.467619259157377
#215140 GREENBERG DYSPLASIA; GRBGD;;HYDROPS-ECTOPIC CALCIFICATION-MOTH-EATEN SKELETAL DYSPLASIA;;HEM SKELETAL DYSPLASIA;;MOTH-EATEN SKELETAL DYSPLASIA;;CHONDRODYSTROPHY, HYDROPIC AND PRENATALLY LETHAL TYPE	0.25	16.467619259157377
HYPERPARATHYROIDISM 2	0.25	16.467619259157377
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.25	16.467619259157377
#613908 SPINOCEREBELLAR ATAXIA 35; SCA35	0.25	16.467619259157377
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.25	16.467619259157377
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.25	16.467619259157377
DYSTONIA 6, TORSION	0.25	16.467619259157377
223540 DWARFISM, MENTAL RETARDATION, AND EYE ABNORMALITY;;MOLLICA SYNDROME	0.25	16.467619259157377
#604364 EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI; FFEVF;;EPILEPSY, PARTIAL, WITH VARIABLE FOCI; FPEVF	0.25	16.467619259157377
HYPEREKPLEXIA 1; HKPX1	0.25	16.467619259157377
#215400 CHORDOMA, SUSCEPTIBILITY TO; CHDM	0.25	16.467619259157377
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.225923551	14.881692078179299
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.22472525100000001	14.802759485546305
FEBRILE SEIZURES, FAMILIAL, 4; FEB4	0.2244281	14.783186007424392
FEBRILE SEIZURES, FAMILIAL, 6; FEB6	0.2244281	14.783186007424392
FEBRILE SEIZURES, FAMILIAL, 2; FEB2	0.2244281	14.783186007424392
FEBRILE SEIZURES, FAMILIAL, 5; FEB5	0.2244281	14.783186007424392
%121210 FEBRILE SEIZURES, FAMILIAL, 1; FEB1;;CONVULSIONS, FAMILIAL FEBRILE;  1	0.2244281	14.783186007424392
NOONAN SYNDROME 6; NS6	0.22125208200000002	14.573980186687471
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.21233818200000001	13.98681734143066
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.20175963300000002	13.2900032724453
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.200843882	13.229682317228528
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.200843882	13.229682317228528
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.200843882	13.229682317228528
Oliver-McFarlane syndrome	0.2	13.174095407325904
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.2	13.174095407325904
TRICHORHINOPHALANGEAL SYNDROME, TYPE I	0.1964286	12.938845585637285
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.194414082	12.806148323978409
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.182143382	11.997871461405039
#613863 GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 7; GEFSP7;;GEFS+, TYPE 7; GEFS+7FEBRILE SEIZURES, FAMILIAL, 3B, INCLUDED; FEB3B, INCLUDED	0.1812995	11.942284551502414
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.149653382	9.857739662484946
ECTODERMAL DYSPLASIA 13, HAIR/TOOTH TYPE; ECTD13	0.1488095	9.802152752582321
#615369 EPILEPTIC ENCEPHALOPATHY, CHILDHOOD-ONSET; EEOC	0.14637478199999998	9.641776716472652
TUBEROUS SCLEROSIS 2; TSC2	0.146323951	9.638428454254404
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.14370088199999997	9.465645647924406
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.14370088199999997	9.465645647924406
RESTRICTIVE DERMOPATHY, LETHAL	0.14285699999999998	9.410058738021782
ECTODERMAL DYSPLASIA 8, HAIR/TOOTH/NAIL TYPE	0.14285699999999998	9.410058738021782
HYPOTRICHOSIS 11; HYPT11	0.14285699999999998	9.410058738021782
HYPOTRICHOSIS 12; HYPT12	0.14285699999999998	9.410058738021782
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.14285699999999998	9.410058738021782
HYPOTRICHOSIS AND RECURRENT SKIN VESICLES	0.14285699999999998	9.410058738021782
WAARDENBURG SYNDROME, TYPE 1; WS1	0.13611879999999998	8.966210289653564
#613060 EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 10; EIG10GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 5, SUSCEPTIBILITYTO, INCLUDED; GEFS5, INCLUDED;;GEFS+, TYPE 5, SUSCEPTIBILITY TO, INCLUDED;;GEFS+5, SUSCEPTIBILITY TO, INCLUDED;;GEFSP5, SUSCEPTIBILITY TO, INCLUDED;;EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 7, INCLUDED; EJM7,INCLUDED	0.1344245	8.854605940410405
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.13423833300000002	8.842343031311927
#613722 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 12; EIEE12	0.1324787	8.72643516619253
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.132363082	8.71881935337851
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.12675963299999998	8.349717494698085
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIx;;CDG-x	0.125915751	8.294130584795461
#615473 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 17; EIEE17	0.125843882	8.289396539481315
MEIER-GORLIN SYNDROME 7	0.125843882	8.289396539481315
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.125843882	8.289396539481315
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.125843882	8.289396539481315
#604233 GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 1; GEFSP1;;GEFS+, TYPE 1; GEFS+1	0.1257439	8.282810677446237
EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 2; EDSCLL2	0.125	8.233809629578689
HYPOTRICHOSIS 5; HYPT5	0.125	8.233809629578689
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.125	8.233809629578689
#193510 WAARDENBURG SYNDROME, TYPE 2A; WS2A;;WAARDENBURG SYNDROME, TYPE IIA;;WAARDENBURG SYNDROME WITHOUT DYSTOPIA CANTHORUM;;WS2	0.12260529999999999	8.076069598219073
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.12032090000000001	7.925595080476596
#612292 BIRK-BAREL MENTAL RETARDATION DYSMORPHISM SYNDROME;;BIRK-BAREL SYNDROME;;MENTAL RETARDATION WITH HYPOTONIA AND FACIAL DYSMORPHISM	0.1166177	7.681663529914551
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.11287063299999998	7.434842439136337
WAARDENBURG-SHAH SYNDROME	0.11195488199999999	7.374521483919567
TIETZ SYNDROME	0.11111099999999999	7.318934574016941
#613266 WAARDENBURG SYNDROME, TYPE 4C; WS4C;;WAARDENBURG SYNDROME WITH HIRSCHSPRUNG DISEASE, TYPE 4C;;WAARDENBURG SYNDROME, TYPE IVC	0.11111099999999999	7.318934574016941
WAARDENBURG SYNDROME, TYPE 4B; WS4B	0.11111099999999999	7.318934574016941
ERMINE PHENOTYPE	0.11111099999999999	7.318934574016941
MYOCLONIC EPILEPSY, FAMILIAL INFANTILE	0.1081087	7.12117164080987
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.10603868200000001	6.98481856767546
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.104163033	6.861268673292183
RENPENNING SYNDROME 1; RENS1	0.101756151	6.702726207781307
#262600 PITUITARY HORMONE DEFICIENCY, COMBINED, 2; CPHD2;;PANHYPOPITUITARISM;;ATELIOTIC DWARFISM WITH HYPOGONADISM;;PITUITARY DWARFISM III;;HANHART DWARFISM	0.10091575100000001	6.647368658879723
WHITE-SUTTON SYNDROME; WHSUS	0.10084388200000001	6.642634613565577
3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY	0.1	6.587047703662952
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.1	6.587047703662952
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.1	6.587047703662952
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.1	6.587047703662952
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.1	6.587047703662952
#256450 HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1; HHF1;;PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA OF INFANCY; PHHI;;HYPOGLYCEMIA, HYPERINSULINEMIC, OF INFANCY;;HYPERINSULINEMIC HYPOGLYCEMIA DUE TO FOCAL ADENOMATOUS HYPERPLASIA;;NESIDIOBLASTOSIS OF PANCREAS;;HYPERINSULINISM, FAMILIAL, WITH PANCREATIC NESIDIOBLASTOSIS;;HYPERINSULINISM, CONGENITAL	0.1	6.587047703662952
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.1	6.587047703662952
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.1	6.587047703662952
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.09663488200000002	6.365385775718405
AU-KLINE SYNDROME; AUKS	0.09608198200000001	6.3289659889648515
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.094910382	6.251792138068736
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.09424668200000001	6.2080739024595255
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.09266873300000002	6.104133649090053
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.09266873300000002	6.104133649090053
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.09266873300000002	6.104133649090053
AYME-GRIPP SYNDROME; AYGRP	0.09182485100000001	6.048546739187428
MOWAT-WILSON SYNDROME; MOWS	0.09182485100000001	6.048546739187428
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.09175298200000001	6.043812693873282
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0902965	5.947873529738017
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.08973155099999999	5.91066006960665
#614018 EPILEPSY, PROGRESSIVE MYOCLONIC, 6; EPM6	0.0888158	5.85033911438988
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.087033282	5.7329238034035015
#300867 KABUKI SYNDROME 2; KABUK2	0.085383333	5.624240875687391
CHROMOSOME 17q12 DELETION SYNDROME	0.0820364	5.403776802367753
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14	0.0788689	5.19513206635423
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.078621682	5.178847698762188
#612437 EPILEPSY, PROGRESSIVE MYOCLONIC 1B; EPM1B	0.078125	5.146131018486681
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.07776698200000001	5.122548202038982
LISSENCEPHALY 2; LIS2	0.07776698200000001	5.122548202038982
MCLEOD SYNDROME; MCLDS	0.07692310000000001	5.066961292136356
#615604 L-FERRITIN DEFICIENCY; LFTD	0.07692310000000001	5.066961292136356
MYOCLONUS AND ATAXIA	0.07692310000000001	5.066961292136356
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.07692310000000001	5.066961292136356
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.07692310000000001	5.066961292136356
CANAVAN DISEASE	0.07692310000000001	5.066961292136356
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.076358482	5.029769635132888
XQ25 DUPLICATION SYNDROME	0.075087233	4.946031857070551
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.0744235	4.902311447735597
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.0744235	4.902311447735597
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.073188233	4.820943821177991
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.073068033	4.8130261898381885
POTOCKI-SHAFFER SYNDROME	0.07234435100000002	4.765356911275367
ICHTHYOSIS--CHEEK--EYEBROW SYNDROME	0.07142860000000001	4.705035956058596
257960 OCULOTRICHODYSPLASIA; OTD	0.07142860000000001	4.705035956058596
DUBOWITZ SYNDROME	0.07142860000000001	4.705035956058596
ECTODERMAL DYSPLASIA 11B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE; ECTD11B	0.07142860000000001	4.705035956058596
HAMAMY SYNDROME; HMMS	0.07142860000000001	4.705035956058596
ULNAR-MAMMARY SYNDROME; UMS	0.07142860000000001	4.705035956058596
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.0714285	4.705029369010892
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.0714285	4.705029369010892
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.0702615	4.628158522309145
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.0702615	4.628158522309145
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.06984130000000001	4.600479747858354
Retinitis pigmentosa with or without skeletal anomalies	0.068871082	4.536571025368828
EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10	0.064163	4.22644741810126
FEBRILE SEIZURES, FAMILIAL, 8; FEB8	0.0632439	4.165905862656894
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1	0.0632439	4.165905862656894
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.062892133	4.14273480256115
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.062748582	4.133279029712064
MENTAL RETARDATION, X-LINKED 98; MRX98	0.062568333	4.121405942096689
ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC, X-LINKED; XHED	0.0619047	4.07769211980944
#254770 EPILEPSY, MYOCLONIC JUVENILE; EJM;;MYOCLONIC EPILEPSY, JUVENILE; JME;;PETIT MAL, IMPULSIVE;;JANZ SYNDROMEMYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 1, INCLUDED; EJM1,INCLUDED	0.0598896	3.9449565215329274
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.0598141	3.939983300516662
EPILEPSY, IDIOPATHIC GENERALIZED	0.0566467	3.7313451515508413
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.056471351	3.7197948292729452
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.056399482	3.7150607839588
COFFIN-LOWRY SYNDROME; CLS	0.05603615099999999	3.691127997666604
APNEA, OBSTRUCTIVE SLEEP	0.055555600000000004	3.659473874056175
#300491 EPILEPSY, X-LINKED, WITH VARIABLE LEARNING DISABILITIES AND BEHAVIORDISORDERS	0.055555600000000004	3.659473874056175
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.055555600000000004	3.659473874056175
#300643 ROLANDIC EPILEPSY, MENTAL RETARDATION, AND SPEECH DYSPRAXIA, X-LINKED;RESDX	0.055555600000000004	3.659473874056175
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.055555600000000004	3.659473874056175
EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8	0.055555600000000004	3.659473874056175
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.055555600000000004	3.659473874056175
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.055555600000000004	3.659473874056175
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.051488599999999995	3.3915786439482023
#208900 ATAXIA-TELANGIECTASIA; AT;;AT1;;LOUIS-BAR SYNDROMEAT, COMPLEMENTATION GROUP A, INCLUDED; ATA, INCLUDED;;AT, COMPLEMENTATION GROUP C, INCLUDED; ATC, INCLUDED;;AT, COMPLEMENTATION GROUP D, INCLUDED; ATD, INCLUDED;;AT, COMPLEMENTATION GROUP E, INCLUDED; ATE, INCLUDED;;ATAXIA-TELANGIECTASIA VARIANT, INCLUDED	0.050735750999999996	3.341988121181653
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.050297633	3.3131290795233195
EPILEPSY, PYRIDOXINE-DEPENDENT	0.050042682	3.2963353355323535
JABERI-ELAHI SYNDROME; JABELS	0.049378633000000005	3.252594111126657
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.049378633000000005	3.252594111126657
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.049378633000000005	3.252594111126657
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.049378633	3.252594111126656
MANDIBULOFACIAL DYSOSTOSIS WITH MACROBLEPHARON AND MACROSTOMIA	0.048817299999999994	3.2156188386402538
KABUKI SYNDROME 1	0.048648633	3.204508662889917
FEBRILE CONVULSIONS, FAMILIAL, 9	0.048538	3.1972212144039234
%614280 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9	0.048538	3.1972212144039234
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.048534751	3.1970072012240314
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.048534751	3.1970072012240314
GAPO SYNDROME; GAPOS	0.048534751	3.1970072012240314
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.048462882	3.192273155909886
#615280 CARDIOFACIOCUTANEOUS SYNDROME 4; CFC4	0.048462882	3.192273155909886
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.048462882	3.192273155909886
#615278 CARDIOFACIOCUTANEOUS SYNDROME 2; CFC2	0.048462882	3.192273155909886
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.048462882	3.192273155909886
#156200 MENTAL RETARDATION, AUTOSOMAL DOMINANT 1; MRD1CHROMOSOME 2q23.1 DELETION SYNDROME, INCLUDED	0.047930799999999996	3.157224660747282
#219000 FRASER SYNDROME;;CRYPTOPHTHALMOS WITH OTHER MALFORMATIONSCRYPTOPHTHALMOS-SYNDACTYLY SYNDROME, INCLUDED	0.047619	3.1366862460072613
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.047619	3.1366862460072613
MACROCEPHALY, ACQUIRED, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; MACID	0.047619	3.1366862460072613
TOOTH AGENESIS, SELECTIVE, 8; STHAG8	0.047619	3.1366862460072613
TOOTH AGENESIS, SELECTIVE, 4	0.047619	3.1366862460072613
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA SYNDROME; HLTS	0.047619	3.1366862460072613
OROFACIAL CLEFT 15	0.047619	3.1366862460072613
BARTSOCAS-PAPAS SYNDROME; BPS	0.047619	3.1366862460072613
HYPOTRICHOSIS 10; HYPT10	0.047619	3.1366862460072613
SPASTIC PARAPLEGIA WITH NEUROPATHY AND POIKILODERMA	0.047619	3.1366862460072613
HYPOTRICHOSIS 1; HYPT1	0.047619	3.1366862460072613
#602032 ECTODERMAL DYSPLASIA 4, HAIR/NAIL TYPE; ECTD4;;ECTODERMAL DYSPLASIA, 'PURE' HAIR/NAIL TYPE	0.047619	3.1366862460072613
ABSENT EYEBROWS AND EYELASHES WITH MENTAL RETARDATION	0.047619	3.1366862460072613
#613456 FRONTONASAL DYSPLASIA 3; FND3	0.047619	3.1366862460072613
PARC SYNDROME	0.047619	3.1366862460072613
PORPHYRIA, CONGENITAL ERYTHROPOIETIC; CEP	0.047619	3.1366862460072613
601375 ECTODERMAL DYSPLASIA, HIDROTIC, CHRISTIANSON-FOURIE TYPE	0.047619	3.1366862460072613
ABLEPHARON-MACROSTOMIA SYNDROME	0.047619	3.1366862460072613
KERATOSIS FOLLICULARIS, DWARFISM, AND CEREBRAL ATROPHY	0.047619	3.1366862460072613
KERATOSIS PILARIS ATROPHICANS; KPA	0.047619	3.1366862460072613
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.047032551	3.0980565706196064
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.046259881999999995	3.0471604949981907
#230600 GM1-GANGLIOSIDOSIS, TYPE II;;GANGLIOSIDOSIS, GENERALIZED GM1, JUVENILE TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE II;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 2GANGLIOSIDOSIS, GENERALIZED GM1, LATE-INFANTILE TYPE, INCLUDED	0.045928	3.0252992693383205
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.042784682	2.818247413200496
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.042677400000000004	2.811180696683053
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.041865582	2.7577058577561298
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.041865582	2.7577058577561298
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	0.0410217	2.7021189478535055
KBG SYNDROME	0.039082633	2.5743916795575186
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.038962533	2.56648063526542
ECTODERMAL DYSPLASIA WITH NATAL TEETH, TURNPENNY TYPE	0.0380952	2.5093489968058087
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.0380952	2.5093489968058087
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.038046782	2.5061596800486496
#614701 CORNELIA DE LANGE SYNDROME 4; CDLS4	0.038046782	2.5061596800486496
ALAZAMI-YUAN SYNDROME	0.038046782	2.5061596800486496
GOLDBERG-SHPRINTZEN SYNDROME	0.038046782	2.5061596800486496
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.037351782	2.460379698508192
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4	0.0369281	2.4324715630563585
FEBRILE SEIZURES, FAMILIAL, 11; FEB11	0.0369281	2.4324715630563585
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.036848482	2.4272270874156563
TEEBI-SHALTOUT SYNDROME; TBSH	0.0360046	2.3716401775130307
FONTAINE PROGEROID SYNDROME; FPS	0.035303799999999996	2.325478147205761
#613721 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 11; EIEE11	0.034417682	2.267109131835017
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.034417682	2.267109131835017
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.0335738	2.211522221932392
#128200 EPISODIC KINESIGENIC DYSKINESIA 1; EKD1;;PAROXYSMAL KINESIGENIC CHOREOATHETOSIS; PKC;;PAROXYSMAL KINESIGENIC DYSKINESIA; PKD;;DYSTONIA, FAMILIAL PAROXYSMAL;;DYSTONIA 10; DYT10	0.031218750999999996	2.0563940208577547
MENKES DISEASE	0.031218750999999996	2.0563940208577547
15q13.3 microdeletion syndrome	0.031218750999999996	2.0563940208577547
#616341 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 30; EIEE30	0.031174782	2.0534977618529315
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.031146881999999997	2.0516599755436093
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.031146881999999997	2.0516599755436093
#257300 MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 1; MVA1;;MVA SYNDROME	0.0303309	1.9979108519503064
MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4	0.0303309	1.9979108519503064
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.0303309	1.9979108519503064
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.0303309	1.9979108519503064
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.0303309	1.9979108519503064
#133540 COCKAYNE SYNDROME, TYPE B; CSB;;CKN2	0.030327550999999998	1.9976902517227102
%135750 LAURIN-SANDROW SYNDROME;;LSS;;SANDROW SYNDROME;;MIRROR HANDS AND FEET WITH NASAL DEFECTS;;TETRAMELIC MIRROR-IMAGE POLYDACTYLY; TMIP;;MIRROR-IMAGE POLYDACTYLY; MIP;;FIBULA AND ULNA, DUPLICATION OF, WITH ABSENCE OF TIBIA AND RADIUSLAURIN-SANDROW SYNDROME, SEGMENTAL, INCLUDED	0.030302999999999997	1.996073065640984
DWARFISM, LEVI TYPE	0.030302999999999997	1.996073065640984
#604367 LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 3; FPLD3;;LIPODYSTROPHY, FAMILIAL PARTIAL, ASSOCIATED WITH PPARG MUTATIONS	0.030302999999999997	1.996073065640984
WAARDENBURG SYNDROME, TYPE IIB	0.030302999999999997	1.996073065640984
EDINBURGH MALFORMATION SYNDROME	0.030302999999999997	1.996073065640984
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.030302999999999997	1.996073065640984
208081 ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTICFACIES	0.030302999999999997	1.996073065640984
NASAL ALAR COLLAPSE, BILATERAL	0.030302999999999997	1.996073065640984
OROFACIAL CLEFT 3	0.030302999999999997	1.996073065640984
22q11.2 distal deletion syndrome	0.030302999999999997	1.996073065640984
211930 CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA	0.030302999999999997	1.996073065640984
Growth hormone deficiency, isolated, type IA	0.030302999999999997	1.996073065640984
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.030302999999999997	1.996073065640984
CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	0.030302999999999997	1.996073065640984
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.030302999999999997	1.996073065640984
CLEFT CHIN	0.030302999999999997	1.996073065640984
#230650 GM1-GANGLIOSIDOSIS, TYPE III;;GANGLIOSIDOSIS, GENERALIZED GM1, ADULT TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, CHRONIC TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE III;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 3	0.030302999999999997	1.996073065640984
15q24 recurrent microdeletion syndrome	0.030302999999999997	1.996073065640984
NASAL GROOVE, FAMILIAL TRANSVERSE	0.030302999999999997	1.996073065640984
SPEECH-LANGUAGE DISORDER 1	0.030302999999999997	1.996073065640984
FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION	0.030302999999999997	1.996073065640984
#219100 CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IA; ARCL1A;;ARCL1;;CUTIS LAXA, AUTOSOMAL RECESSIVE	0.030302999999999997	1.996073065640984
DIMPLES, FACIAL	0.030302999999999997	1.996073065640984
OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION	0.030302999999999997	1.996073065640984
NASAL BONES, ABSENCE OF	0.030302999999999997	1.996073065640984
CYANIDE, INABILITY TO SMELL	0.030302999999999997	1.996073065640984
OSTEOPENIA AND SPARSE HAIR	0.030302999999999997	1.996073065640984
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.030255682	1.992956206408565
RED SKIN PIGMENT ANOMALY OF NEW GUINEA	0.0294118	1.93736929650594
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.0294118	1.93736929650594
HAIRY NOSE TIP	0.0294118	1.93736929650594
AMELOONYCHOHYPOHIDROTIC SYNDROME	0.0294118	1.93736929650594
#206920 MICROPHTHALMIA WITH LIMB ANOMALIES;;WAARDENBURG ANOPHTHALMIA SYNDROME;;ANOPHTHALMIA-SYNDACTYLY;;OPHTHALMOACROMELIC SYNDROME; OAS	0.0294118	1.93736929650594
138920 GRANDDAD SYNDROME;;GROWTH RETARDATION, AGED FACIES, NORMAL DEVELOPMENT, DECREASED SUBCUTANEOUSFAT, AUTOSOMAL DOMINANT INHERITANCE	0.0294118	1.93736929650594
VAN BOGAERT-HOZAY SYNDROME	0.0294118	1.93736929650594
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.0294118	1.93736929650594
CATATRICHY	0.0294118	1.93736929650594
WERNER SYNDROME; WRN	0.0294118	1.93736929650594
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 6	0.0294118	1.93736929650594
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 2	0.0294118	1.93736929650594
SCALP-EAR-NIPPLE SYNDROME; SENS	0.0294118	1.93736929650594
ICHTHYOSIS, SPLIT HAIRS, AND AMINO ACIDURIA	0.0294118	1.93736929650594
%152800 LYMPHANGIECTASIA, INTESTINAL	0.0294118	1.93736929650594
TRICHODISCOMAS, FAMILIAL MULTIPLE	0.0294118	1.93736929650594
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.0294118	1.93736929650594
MANITOBA OCULOTRICHOANAL SYNDROME	0.0294118	1.93736929650594
MIDPHALANGEAL HAIR	0.0294118	1.93736929650594
ANTERIOR CHAMBER CLEAVAGE DISORDER, CEREBELLAR HYPOPLASIA, HYPOTHYROIDISM, AND TRACHEAL STENOSIS	0.0294118	1.93736929650594
#250460 METAPHYSEAL DYSPLASIA WITHOUT HYPOTRICHOSIS;;CARTILAGE-HAIR HYPOPLASIA-LIKE SKELETAL DYSPLASIA WITHOUT HYPOTRICHOSISOR IMMUNODEFICIENCY;;CARTILAGE-HAIR HYPOPLASIA VARIANT, SKELETAL MANIFESTATIONS ONLY; CHHV	0.0294118	1.93736929650594
ALBINISM, OCULOCUTANEOUS, TYPE VI; OCA6	0.0294118	1.93736929650594
611426 TENTED EYEBROWS	0.0294118	1.93736929650594
HAIR WHORL	0.0294118	1.93736929650594
PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS; PPSH	0.0294118	1.93736929650594
RINGED HAIR	0.0294118	1.93736929650594
TRICHODENTOOSSEOUS SYNDROME	0.0294118	1.93736929650594
HERMANSKY-PUDLAK SYNDROME 1; HPS1	0.0294118	1.93736929650594
HALLERMANN-STREIFF SYNDROME; HSS	0.0289916	1.9096905220551483
#614976 CARPENTER SYNDROME 2; CRPT2	0.027324682000000003	1.7998898382142043
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.027324682000000003	1.7998898382142043
MENTAL RETARDATION, X-LINKED 41	0.027159682	1.78902120950316
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.027159682	1.78902120950316
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.027159682	1.78902120950316
HAREL-YOON SYNDROME; HAYOS	0.027159682	1.78902120950316
#616351 MENTAL RETARDATION, AUTOSOMAL DOMINANT 34; MRD34	0.027044082	1.7814065823577259
DESANTO-SHINAWI SYNDROME	0.026767433	1.763183580756019
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.026767433	1.763183580756019
WIEDEMANN-STEINER SYNDROME; WDSTS	0.026767433	1.763183580756019
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.026552482000000002	1.7490246558465188
CHAR SYNDROME	0.026552482	1.7490246558465186
SIMOSA CRANIOFACIAL SYNDROME	0.0264808	1.744302928311579
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.0264808	1.744302928311579
MYOCLONIC-ATONIC EPILEPSY	0.0263158	1.733434299600535
CHROMOSOME Xp11.23-p11.22 DUPLICATION SYNDROME	0.0263158	1.733434299600535
#612269 EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 5; ECA5	0.0263158	1.733434299600535
ZIMMERMANN-LABAND SYNDROME 1	0.025923550999999996	1.7075966708533938
#252940 MUCOPOLYSACCHARIDOSIS, TYPE IIID; MPS3D;;MPS IIID;;SANFILIPPO SYNDROME D;;N-ACETYLGLUCOSAMINE-6-SULFATASE DEFICIENCY	0.025923550999999996	1.7075966708533938
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.025923550999999996	1.7075966708533938
ELSAHY-WATERS SYNDROME; ESWS	0.025851682	1.7028626255392487
HOLOPROSENCEPHALY 11	0.025851681999999997	1.7028626255392487
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.025708599999999998	1.6934377459438936
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.025569133	1.684250988123026
GLASS SYNDROME	0.025569133	1.684250988123026
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.025449033	1.676339943830927
CHROMOSOME 3pter-p25 DELETION SYNDROME	0.025449033	1.676339943830927
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.025449033	1.676339943830927
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.025449033	1.676339943830927
228560 FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES	0.025007799999999997	1.6472757156366233
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.025007799999999997	1.6472757156366233
MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4	0.025007799999999997	1.6472757156366233
MARSHALL-SMITH SYNDROME; MRSHSS	0.025007799999999997	1.6472757156366233
AMAUROSIS CONGENITA, CONE-ROD TYPE, WITH CONGENITAL HYPERTRICHOSIS	0.025007799999999997	1.6472757156366233
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.025007799999999997	1.6472757156366233
#102500 HAJDU-CHENEY SYNDROME; HJCYS;;ACROOSTEOLYSIS WITH OSTEOPOROSIS AND CHANGES IN SKULL AND MANDIBLE;;CHENEY SYNDROME;;ARTHRODENTOOSTEODYSPLASIA;;SERPENTINE FIBULA-POLYCYSTIC KIDNEY SYNDROME; SFPKS	0.025007799999999997	1.6472757156366233
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.024725251	1.6286640782204012
DYSOSTEOSCLEROSIS	0.024725251	1.6286640782204012
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.024725251	1.6286640782204012
OCULOSKELETODENTAL SYNDROME; OCSKD	0.024653382	1.6239300329062556
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.024653382	1.6239300329062556
#607694 LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OR WITHOUT OLIGODONTIA AND/ORHYPOGONADOTROPIC HYPOGONADISM; HLD7;;LEUKOENCEPHALOPATHY, HYPOMYELINATING, WITH ATAXIA AND DELAYED DENTITION;;ATAXIA, DELAYED DENTITION, AND HYPOMYELINATION; ADDH;;LEUKODYSTROPHY, HYPOMYELINATING, WITH HYPODONTIA AND HYPOGONADOTROPICHYPOGONADISM;;4H SYNDROME	0.024653382	1.6239300329062556
CORNELIA DE LANGE SYNDROME 1	0.024605151	1.6207530339283016
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.024533282	1.616018988614156
EVEN-PLUS SYNDROME	0.024533282	1.616018988614156
Temtamy preaxial brachydactyly syndrome	0.024533282	1.616018988614156
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.024533282	1.616018988614156
#615516 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 38; MRT38	0.023981833	1.5796947799227838
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.0238095	1.5683431230036307
#608615 OLIGODONTIA-COLORECTAL CANCER SYNDROME; ODCRCS;;TOOTH AGENESIS-COLORECTAL CANCER SYNDROME	0.0238095	1.5683431230036307
#103285 ADULT SYNDROME;;ACRO-DERMATO-UNGUAL-LACRIMAL-TOOTH SYNDROME	0.0238095	1.5683431230036307
DENTAL ANOMALIES AND SHORT STATURE; DASS	0.0238095	1.5683431230036307
191482 UNCOMBABLE HAIR, RETINAL PIGMENTARY DYSTROPHY, DENTAL ANOMALIES, ANDBRACHYDACTYLY;;BORK SYNDROME	0.0238095	1.5683431230036307
TEETH, CONGENITAL ABSENCE OF, WITH TAURODONTIA AND SPARSE HAIR	0.0238095	1.5683431230036307
221810 DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE;;KIRGHIZIAN DERMATOOSTEOLYSIS	0.0238095	1.5683431230036307
FOCAL DERMAL HYPOPLASIA; FDH	0.0238095	1.5683431230036307
%613857 OROFACIAL CLEFT 13; OFC13	0.0238095	1.5683431230036307
DEAFNESS-OLIGODONTIA SYNDROME	0.0238095	1.5683431230036307
#604625 TOOTH AGENESIS, SELECTIVE, 3; STHAG3;;HYPODONTIA/OLIGODONTIA 3	0.0238095	1.5683431230036307
ICHTHYOSIS, LEUKOCYTE VACUOLES, ALOPECIA, AND SCLEROSING CHOLANGITIS; ILVASC	0.0238095	1.5683431230036307
ZECHI-CEIDE SYNDROME	0.0238095	1.5683431230036307
BRACHYDACTYLY, TYPE E2; BDE2	0.0238095	1.5683431230036307
LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM	0.0238095	1.5683431230036307
SECKEL SYNDROME 5; SCKL5	0.0238095	1.5683431230036307
CHERUBISM	0.0238095	1.5683431230036307
TOOTH AGENESIS, SELECTIVE, X-LINKED, 1	0.0238095	1.5683431230036307
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.0238095	1.5683431230036307
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.023137951	1.5241078700201591
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.023066082	1.5193738247060136
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.023066082	1.5193738247060136
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.023066082	1.5193738247060136
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.023066082	1.5193738247060136
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.0222222	1.4637869148033884
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.0222222	1.4637869148033884
MENTAL RETARDATION, X-LINKED 77	0.0222222	1.4637869148033884
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.0222222	1.4637869148033884
EPILEPSY, HOT WATER, 1	0.0222222	1.4637869148033884
EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6	0.0222222	1.4637869148033884
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.0222222	1.4637869148033884
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.022167832999999998	1.460205734578338
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.022167832999999998	1.460205734578338
SMITH-KINGSMORE SYNDROME; SKS	0.021323950999999997	1.4046188246757128
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.021323950999999997	1.4046188246757128
NEUROFIBROMATOSIS, TYPE II	0.021323950999999997	1.4046188246757128
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.021252082	1.3998847793615674
#300895 OHDO SYNDROME, X-LINKED; OHDOX;;BLEPHAROPHIMOSIS-MENTAL RETARDATION SYNDROME, MAAT-KIEVIT-BRUNNERTYPE	0.021252082	1.3998847793615674
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.021252082	1.3998847793615674
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.021252082	1.3998847793615674
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.021252082	1.3998847793615674
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.021252082	1.3998847793615674
SILVER-RUSSELL SYNDROME; SRS	0.021252082	1.3998847793615674
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.021252082	1.3998847793615674
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.021252082	1.3998847793615674
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.020627533	1.3587454387988176
HYPERPROLINEMIA, TYPE I	0.020627533	1.3587454387988176
NF1-microdeletion syndrome	0.020408199999999998	1.3442978694589425
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 2; AHMIO2	0.020408199999999998	1.3442978694589425
FANCONI ANEMIA, COMPLEMENTATION GROUP D1	0.020408199999999998	1.3442978694589425
LEGIUS SYNDROME	0.020408199999999998	1.3442978694589425
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.020408199999999998	1.3442978694589425
#151100 LEOPARD SYNDROME 1;;LENTIGINOSIS, CARDIOMYOPATHIC;;MULTIPLE LENTIGINES SYNDROME	0.020408199999999998	1.3442978694589425
MISMATCH REPAIR CANCER SYNDROME; MMRCS	0.020408199999999998	1.3442978694589425
Mulchandani-Bhoj-Conlin syndrome	0.020408199999999998	1.3442978694589425
PHEOCHROMOCYTOMA	0.020408199999999998	1.3442978694589425
FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP	0.020408199999999998	1.3442978694589425
JOHANSON-BLIZZARD SYNDROME; JBS	0.020408199999999998	1.3442978694589425
#611554 LEOPARD SYNDROME 2	0.020408199999999998	1.3442978694589425
#227645 FANCONI ANEMIA, COMPLEMENTATION GROUP C; FANCC;;FACC; FAC;;FANCONI PANCYTOPENIA, TYPE 3; FA3	0.020408199999999998	1.3442978694589425
PHEOCHROMOCYTOMA--ISLET CELL TUMOR SYNDROME	0.020408199999999998	1.3442978694589425
ROBERTS SYNDROME; RBS	0.020408199999999998	1.3442978694589425
#610832 FANCONI ANEMIA, COMPLEMENTATION GROUP N; FANCN	0.020408199999999998	1.3442978694589425
BLOOM SYNDROME	0.020408199999999998	1.3442978694589425
#162210 NEUROFIBROMATOSIS, FAMILIAL SPINAL;;FSNF	0.020408199999999998	1.3442978694589425
RUSSELL-SILVER SYNDROME, X-LINKED	0.020408199999999998	1.3442978694589425
NIJMEGEN BREAKAGE SYNDROME	0.020408199999999998	1.3442978694589425
MULTIPLE ENDOCRINE NEOPLASIA, TYPE I	0.020408199999999998	1.3442978694589425
#227646 FANCONI ANEMIA, COMPLEMENTATION GROUP D2; FANCD2;;FAD2;;FANCONI ANEMIA, COMPLEMENTATION GROUP D; FANCD; FACD;;FANCONI PANCYTOPENIA, TYPE 4; FA4	0.020408199999999998	1.3442978694589425
FANCONI ANEMIA	0.020408199999999998	1.3442978694589425
GASTROCUTANEOUS SYNDROME	0.020408199999999998	1.3442978694589425
HYPERPIGMENTATION, FAMILIAL PROGRESSIVE	0.020408199999999998	1.3442978694589425
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.019711782	1.298424483582047
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.019711782	1.298424483582047
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.019711782	1.298424483582047
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.019711782	1.298424483582047
PEHO-LIKE SYNDROME; PEHOL	0.019711782	1.298424483582047
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.019711782	1.298424483582047
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.019711782	1.298424483582047
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.019711782	1.298424483582047
FUMARASE DEFICIENCY; FMRD	0.019711782	1.298424483582047
RING CHROMOSOME 14 SYNDROME	0.019711782	1.298424483582047
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.019711782	1.298424483582047
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.019711782	1.298424483582047
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.019711782	1.298424483582047
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.019711782	1.298424483582047
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.019711782	1.298424483582047
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.019711782	1.298424483582047
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.019711782	1.298424483582047
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.019711782	1.298424483582047
BETA-UREIDOPROPIONASE DEFICIENCY	0.019711782	1.298424483582047
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.019711782	1.298424483582047
Congenital disorder of glycosylation, type IIh	0.019711782	1.298424483582047
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.019711782	1.298424483582047
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0188679	1.2428375736794222
DIASTEMATOMYELIA	0.0188679	1.2428375736794222
ALPHA-METHYLACYL-CoA RACEMASE DEFICIENCY; AMACRD	0.0188679	1.2428375736794222
RHEUMATOID ARTHRITIS	0.0188679	1.2428375736794222
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0188679	1.2428375736794222
269800 SENILE PLAQUE FORMATION	0.0188679	1.2428375736794222
ENDOCARDIAL FIBROELASTOSIS	0.0188679	1.2428375736794222
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0188679	1.2428375736794222
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0188679	1.2428375736794222
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0188679	1.2428375736794222
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0188679	1.2428375736794222
THUMBS, CONGENITAL CLASPED	0.0188679	1.2428375736794222
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0188679	1.2428375736794222
COGNITIVE FUNCTION 1, SOCIAL	0.0188679	1.2428375736794222
PALMOMENTAL REFLEX	0.0188679	1.2428375736794222
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0188679	1.2428375736794222
141405 HEMIFACIAL SPASM, FAMILIAL	0.0188679	1.2428375736794222
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0188679	1.2428375736794222
MOTION SICKNESS	0.0188679	1.2428375736794222
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0188679	1.2428375736794222
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0188679	1.2428375736794222
#259420 OSTEOGENESIS IMPERFECTA, TYPE III;;OI, TYPE III;;OI3;;OSTEOGENESIS IMPERFECTA, PROGRESSIVELY DEFORMING, WITH NORMAL SCLERAE	0.0188679	1.2428375736794222
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0188679	1.2428375736794222
#610189 SENIOR-LOKEN SYNDROME 6; SLSN6	0.0188679	1.2428375736794222
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0188679	1.2428375736794222
NOVELTY SEEKING PERSONALITY TRAIT	0.0188679	1.2428375736794222
TRANSSEXUALITY	0.0188679	1.2428375736794222
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0188679	1.2428375736794222
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0188679	1.2428375736794222
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.0188679	1.2428375736794222
CARDIAC ARRHYTHMIA	0.0188679	1.2428375736794222
ANDROSTENONE, ABILITY TO SMELL	0.0188679	1.2428375736794222
PERONEAL NERVE, ACCESSORY DEEP	0.0188679	1.2428375736794222
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.0188679	1.2428375736794222
JUMPING FRENCHMAN OF MAINE	0.0188679	1.2428375736794222
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0188679	1.2428375736794222
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.0188679	1.2428375736794222
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.0188679	1.2428375736794222
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0188679	1.2428375736794222
MERALGIA PARAESTHETICA, FAMILIAL	0.0188679	1.2428375736794222
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0188679	1.2428375736794222
ALCOHOL DEPENDENCE	0.0188679	1.2428375736794222
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0188679	1.2428375736794222
#601277 ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4A; ARCI4A;;ICHTHYOSIS CONGENITA IIB; ICR2B;;ICHTHYOSIS, LAMELLAR, 2, FORMERLY; LI2, FORMERLY	0.0188679	1.2428375736794222
SPASTIC PSEUDOSCLEROSIS	0.0188679	1.2428375736794222
#220100 CYSTINURIA;;CSNU;;CYSTINURIA, TYPE I, FORMERLY; CSNU1, FORMERLY;;CYSTINURIA, TYPE II, FORMERLY;;CYSTINURIA, TYPE III, FORMERLY; CSNU3, FORMERLY;;CYSTINURIA, TYPE NON-I, FORMERLYCYSTINURIA, TYPE A, INCLUDED;;CYSTINURIA, TYPE B, INCLUDED;;CYSTINURIA, TYPE A/B, INCLUDED	0.0188679	1.2428375736794222
#614652 COENZYME Q10 DEFICIENCY, PRIMARY, 3; COQ10D3	0.0188679	1.2428375736794222
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0188679	1.2428375736794222
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0188679	1.2428375736794222
GRANULOMAS, CONGENITAL CEREBRAL	0.0188679	1.2428375736794222
SPATIAL VISUALIZATION, APTITUDE FOR	0.0188679	1.2428375736794222
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0188679	1.2428375736794222
MYOPATHY, CONGENITAL	0.0188679	1.2428375736794222
ERYTHERMALGIA, PRIMARY	0.0188679	1.2428375736794222
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.0188679	1.2428375736794222
CERVICAL RIB	0.0188679	1.2428375736794222
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.0188679	1.2428375736794222
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0188679	1.2428375736794222
#610127 CEROID LIPOFUSCINOSIS, NEURONAL, 10; CLN10;;CEROID LIPOFUSCINOSIS, NEURONAL, CATHEPSIN D-DEFICIENT;;NEURONAL CEROID LIPOFUSCINOSIS DUE TO CATHEPSIN D DEFICIENCYNEURONAL CEROID LIPOFUSCINOSIS, CONGENITAL, INCLUDED	0.0188679	1.2428375736794222
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0188679	1.2428375736794222
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.017384633	1.1451340688167317
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.016540751	1.0895471589141068
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.016540751	1.0895471589141068
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.016468882	1.0848131135999612
#614457 ICHTHYOSIS, SPASTIC QUADRIPLEGIA, AND MENTAL RETARDATION; ISQMR	0.016468882	1.0848131135999612
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.016468882	1.0848131135999612
#610951 CEROID LIPOFUSCINOSIS, NEURONAL, 7; CLN7	0.016468882	1.0848131135999612
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.016468882	1.0848131135999612
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.016468882	1.0848131135999612
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.016468882	1.0848131135999612
#300868 MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 2; MCAHS2	0.016468882	1.0848131135999612
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.016468882	1.0848131135999612
ROIFMAN-CHITAYAT SYNDROME	0.016468882	1.0848131135999612
#300848 MENTAL RETARDATION, X-LINKED 89; MRX89	0.016468882	1.0848131135999612
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.016468882	1.0848131135999612
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.016468882	1.0848131135999612
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.016468882	1.0848131135999612
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.016468882	1.0848131135999612
HYDROXYLYSINURIA	0.015625	1.029226203697336
CARNOSINEMIA	0.015625	1.029226203697336
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.015625	1.029226203697336
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.015625	1.029226203697336
#609304 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 3; EIEE3	0.015625	1.029226203697336
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.015625	1.029226203697336
PAINE SYNDROME	0.015625	1.029226203697336
MICROHYDRANENCEPHALY; MHAC	0.015625	1.029226203697336
#614706 CEROID LIPOFUSCINOSIS, NEURONAL, 11; CLN11	0.015625	1.029226203697336
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.015625	1.029226203697336
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.015625	1.029226203697336
#231000 GAUCHER DISEASE, TYPE III;;GD III;;GAUCHER DISEASE, SUBACUTE NEURONOPATHIC TYPE;;GAUCHER DISEASE, CHRONIC NEURONOPATHIC TYPE;;GAUCHER DISEASE, JUVENILE AND ADULT, CEREBRALGAUCHER DISEASE, TYPE IIIA, INCLUDED;;GAUCHER DISEASE, TYPE IIIB, INCLUDED;;GAUCHER DISEASE, NORRBOTTNIAN TYPE, INCLUDED	0.015625	1.029226203697336
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.015625	1.029226203697336
MYOCLONIC EPILEPSY, HARTUNG TYPE	0.015625	1.029226203697336
310370 MYOCLONIC EPILEPSY, PROGRESSIVE	0.015625	1.029226203697336
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.015621650999999999	1.0290056034697406
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.015621650999999999	1.0290056034697406
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.015549782	1.024271558155595
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.015549782	1.024271558155595
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.015549782	1.024271558155595
PELGER-HUET ANOMALY; PHA	0.015549782	1.024271558155595
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.015549782	1.024271558155595
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.015549782	1.024271558155595
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.015273133	1.0060485565538884
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIm; CDG2M	0.015273133	1.0060485565538884
COFFIN-SIRIS SYNDROME 4; CSS4	0.015273133	1.0060485565538884
COFFIN-SIRIS SYNDROME 1; CSS1	0.015273133	1.0060485565538884
SCHAAF-YANG SYNDROME; SHFYNG	0.015273133	1.0060485565538884
COFFIN-SIRIS SYNDROME 5	0.015273133	1.0060485565538884
COFFIN-SIRIS SYNDROME 2; CSS2	0.015273133	1.0060485565538884
KLEEFSTRA SYNDROME 2; KLEFS2	0.015273133	1.0060485565538884
COFFIN-SIRIS SYNDROME 3; CSS3	0.015273133	1.0060485565538884
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.015273133	1.0060485565538884
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.015273133	1.0060485565538884
PHELAN-MCDERMID SYNDROME; PHMDS	0.015273133	1.0060485565538884
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.015201451	1.0013268290189488
PALLISTER-KILLIAN SYNDROME	0.015201451	1.0013268290189488
#610768 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Im; CDG1M;;CDG Im; CDGIm;;DOLICHOL KINASE DEFICIENCY;;DK1 DEFICIENCY	0.015201451	1.0013268290189488
OHDO SYNDROME	0.015201451	1.0013268290189488
#252500 MUCOLIPIDOSIS II ALPHA/BETA;;MUCOLIPIDOSIS II; ML II;;ML II ALPHA/BETA;;I-CELL DISEASE; ICD	0.015129582	0.9965927837048033
OGDEN SYNDROME; OGDNS	0.015129582	0.9965927837048033
CDAGS SYNDROME	0.015129582	0.9965927837048033
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.015129582	0.9965927837048033
CEREBELLOFACIODENTAL SYNDROME	0.015129582	0.9965927837048033
NOONAN SYNDROME 9; NS9	0.015129582	0.9965927837048033
NETHERTON SYNDROME; NETH	0.015129582	0.9965927837048033
ROSSELLI-GULIENETTI SYNDROME	0.015129582	0.9965927837048033
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.0147059	0.96868464825297
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.0147059	0.96868464825297
EPILEPSY, BENIGN NEONATAL, 3	0.0147059	0.96868464825297
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.0147059	0.96868464825297
SEIZURES, BENIGN FAMILIAL INFANTILE, 5	0.0147059	0.96868464825297
#607876 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 2; FAME2;;BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY 2; BAFME2;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 2; FCMTE2;;CORTICAL MYOCLONUS AND EPILEPSY, AUTOSOMAL DOMINANT; ADCME	0.0147059	0.96868464825297
#104290 ALTERNATING HEMIPLEGIA OF CHILDHOOD 1; AHC1	0.0147059	0.96868464825297
MYOCLONIC EPILEPSY, JUVENILE, 2	0.0147059	0.96868464825297
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.0147059	0.96868464825297
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.0147059	0.96868464825297
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.0147059	0.96868464825297
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.0147059	0.96868464825297
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.0147059	0.96868464825297
269720 SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;BFNS, AUTOSOMAL RECESSIVE;;CONVULSIONS, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;EPILEPSY, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE	0.0147059	0.96868464825297
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.0147059	0.96868464825297
#230000 FUCOSIDOSIS;;ALPHA-L-FUCOSIDASE DEFICIENCY	0.014429250999999999	0.9504616466512634
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.014429250999999999	0.9504616466512634
TENORIO SYNDROME; TNORS	0.014429250999999999	0.9504616466512634
COFFIN-SIRIS SYNDROME 8; CSS8	0.014429250999999999	0.9504616466512634
COHEN SYNDROME	0.014429250999999999	0.9504616466512634
Myhre syndrome	0.014429250999999999	0.9504616466512634
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIa; CDG2A	0.014429250999999999	0.9504616466512634
COFFIN-SIRIS SYNDROME 7; CSS7	0.014357382	0.945727601337118
CHOPS SYNDROME; CHOPS	0.014357382	0.945727601337118
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.014357382	0.945727601337118
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.014357382	0.945727601337118
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.014357382	0.945727601337118
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.014357382	0.945727601337118
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.014357382	0.945727601337118
KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, X-LINKED; KFSDX	0.0142857	0.9410058738021784
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.0142857	0.9410058738021784
MANDIBULOFACIAL DYSOSTOSIS WITH ALOPECIA; MFDA	0.0142857	0.9410058738021784
ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3; EEC3	0.0142857	0.9410058738021784
#148210 KERATITIS-ICHTHYOSIS-DEAFNESS SYNDROME, AUTOSOMAL DOMINANT;;KID SYNDROME, AUTOSOMAL DOMINANT	0.0142857	0.9410058738021784
NOONAN SYNDROME 10; NS10	0.0142857	0.9410058738021784
KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, AUTOSOMAL DOMINANT; KFSD	0.0142857	0.9410058738021784
SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS	0.0142857	0.9410058738021784
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.0142857	0.9410058738021784
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND CILIARYDYSKINESIA	0.0142857	0.9410058738021784
NESTOR-GUILLERMO PROGERIA SYNDROME; NGPS	0.0142857	0.9410058738021784
CEREBROOCULONASAL SYNDROME	0.0142857	0.9410058738021784
190360 TRICHODYSPLASIA-XERODERMA	0.0142857	0.9410058738021784
ECTODERMAL DYSPLASIA-SYNDACTYLY SYNDROME 1	0.0142857	0.9410058738021784
HYPOTRICHOSIS 7; HYPT7	0.0142857	0.9410058738021784
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.0142857	0.9410058738021784
FRONTONASAL DYSPLASIA 2; FND2	0.0142857	0.9410058738021784
#129500 CLOUSTON SYNDROME;;ECTODERMAL DYSPLASIA 2, CLOUSTON TYPE; ECTD2;;ECTODERMAL DYSPLASIA, HIDROTIC, AUTOSOMAL DOMINANT;;CLOUSTON HIDROTIC ECTODERMAL DYSPLASIA;;ECTODERMAL DYSPLASIA, HIDROTIC, 2, FORMERLY; HED2, FORMERLY	0.0142857	0.9410058738021784
ODONTOONYCHODERMAL DYSPLASIA; OODD	0.0142857	0.9410058738021784
MACS SYNDROME	0.0142857	0.9410058738021784
CARTILAGE-HAIR HYPOPLASIA; CHH	0.0142857	0.9410058738021784
#602540 ICHTHYOSIS, HYSTRIX-LIKE, WITH DEAFNESS;;HID SYNDROME	0.0142857	0.9410058738021784
PACHYONYCHIA CONGENITA 2	0.0142857	0.9410058738021784
#607903 HYPOTRICHOSIS 6; HYPT6;;HYPOTRICHOSIS, LOCALIZED, AUTOSOMAL RECESSIVE 1; LAH1;;HYPOTRICHOSIS, LOCALIZED, AUTOSOMAL RECESSIVE; LAH;;HTL	0.0142857	0.9410058738021784
129540 ECTODERMAL DYSPLASIA SYNDROME WITH DISTINCTIVE FACIAL APPEARANCE ANDPREAXIAL POLYDACTYLY OF FEET	0.0142857	0.9410058738021784
STORM SYNDROME	0.0142857	0.9410058738021784
NAXOS DISEASE; NXD	0.0142857	0.9410058738021784
PALMOPLANTAR KERATODERMA AND WOOLLY HAIR; PPKWH	0.0142857	0.9410058738021784
MARIE UNNA HEREDITARY HYPOTRICHOSIS 1	0.0142857	0.9410058738021784
BARBER-SAY SYNDROME; BBRSAY	0.0142857	0.9410058738021784
HYPOTRICHOSIS 8; HYPT8	0.0142857	0.9410058738021784
#615896 HYPOTRICHOSIS 13; HYPT13;;HYPOTRICHOSIS WITH WOOLLY HAIR	0.0142857	0.9410058738021784
CLEFT LIP/PALATE-ECTODERMAL DYSPLASIA SYNDROME; CLPED1	0.0142857	0.9410058738021784
HAIR DEFECT WITH PHOTOSENSITIVITY AND MENTAL RETARDATION	0.0142857	0.9410058738021784
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 11; ARCI11	0.0142857	0.9410058738021784
#129490 ECTODERMAL DYSPLASIA 10A, HYPOHIDROTIC/HAIR/NAIL TYPE, AUTOSOMAL DOMINANT;ECTD10A;;ECTODERMAL DYSPLASIA, HYPOHIDROTIC, AUTOSOMAL DOMINANT; HED	0.0142857	0.9410058738021784
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.0142857	0.9410058738021784
NOONAN SYNDROME 4; NS4	0.0142857	0.9410058738021784
YUNIS-VARON SYNDROME	0.0142857	0.9410058738021784
ECTODERMAL DYSPLASIA 7, HAIR/NAIL TYPE; ECTD7	0.0142857	0.9410058738021784
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	0.0142857	0.9410058738021784
ECTODERMAL DYSPLASIA, ECTRODACTYLY, AND MACULAR DYSTROPHY SYNDROME	0.0142857	0.9410058738021784
ECTODERMAL DYSPLASIA 10B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE; ECTD10B	0.0142857	0.9410058738021784
SHASHI-PENA SYNDROME; SHAPNS	0.013954733	0.9192049196287962
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.013954733	0.9192049196287962
#194190 WOLF-HIRSCHHORN SYNDROME; WHS;;CHROMOSOME 4p16.3 DELETION SYNDROME;;PITT-ROGERS-DANKS SYNDROME; PRDS;;PITT SYNDROME	0.013954733	0.9192049196287962
Glycosylphosphatidylinositol biosynthesis defect 18	0.013954733	0.9192049196287962
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.013954733	0.9192049196287962
TEMTAMY SYNDROME; TEMTYS	0.013954733	0.9192049196287962
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.013954733	0.9192049196287962
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.013954733	0.9192049196287962
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.013954733	0.9192049196287962
CHROMOSOME 2q37 DELETION SYNDROME	0.013954733	0.9192049196287962
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.013954733	0.9192049196287962
BARAITSER-WINTER SYNDROME 1; BRWS1	0.013954733	0.9192049196287962
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.013954733	0.9192049196287962
MACDERMOT-WINTER SYNDROME	0.013954733	0.9192049196287962
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.0135135	0.890140691434493
HYPERTELORISM AND OTHER FACIAL DYSMORPHISM, BRACHYDACTYLY, GENITAL ABNORMALITIES, MENTAL RETARDATION, AND RECURRENT INFLAMMATORY EPISODES	0.0135135	0.890140691434493
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 45; MRT45	0.0135135	0.890140691434493
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.0135135	0.890140691434493
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.0135135	0.890140691434493
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.0135135	0.890140691434493
DEAFNESS, X-LINKED 7; DFNX7	0.0135135	0.890140691434493
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.0135135	0.890140691434493
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.0135135	0.890140691434493
#273750 THREE M SYNDROME 1; 3M1;;3@M SYNDROME;;LE MERRER SYNDROME;;DOLICHOSPONDYLIC DYSPLASIA;;GLOOMY FACE SYNDROMEYAKUT SHORT STATURE SYNDROME, INCLUDED	0.0135135	0.890140691434493
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.013253932999999999	0.8730428893215261
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.013253932999999999	0.8730428893215261
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.013253932999999999	0.8730428893215261
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.013253932999999999	0.8730428893215261
SMITH-MAGENIS SYNDROME; SMS	0.013253932999999999	0.8730428893215261
#300004 CORPUS CALLOSUM, AGENESIS OF, WITH ABNORMAL GENITALIA;;ACC WITH ABNORMAL GENITALIA;;PROUD SYNDROME	0.013253932999999999	0.8730428893215261
AL KAISSI SYNDROME; ALKAS	0.013253932999999999	0.8730428893215261
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.013253932999999999	0.8730428893215261
#269921 SIALURIA;;SIALURIA, FRENCH TYPE	0.013253932999999999	0.8730428893215261
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.013110851	0.8636180097261711
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.013110851	0.8636180097261711
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.013110851	0.8636180097261711
BARAITSER-WINTER SYNDROME 2; BRWS2	0.013110851	0.8636180097261711
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.013110851	0.8636180097261711
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.013110851	0.8636180097261711
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.013110851	0.8636180097261711
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.013110851	0.8636180097261711
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.013038982000000001	0.8588839644120256
JOUBERT SYNDROME 14	0.013038982000000001	0.8588839644120256
RAINE SYNDROME	0.013038982000000001	0.8588839644120256
CHROMOSOME 9P DELETION SYNDROME	0.013038982000000001	0.8588839644120256
CHROMOSOME 15Q14 DELETION SYNDROME	0.013038982000000001	0.8588839644120256
JOUBERT SYNDROME 35; JBTS35	0.013038982000000001	0.8588839644120256
3MC SYNDROME 2	0.013038982000000001	0.8588839644120256
CHROMOSOME 22q11.2 DELETION SYNDROME, DISTAL	0.013038982000000001	0.8588839644120256
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.013038982000000001	0.8588839644120256
JOUBERT SYNDROME 1	0.013038982000000001	0.8588839644120256
CHROMOSOME 17P13.1 DELETION SYNDROME	0.013038982000000001	0.8588839644120256
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.013038982000000001	0.8588839644120256
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.012410050999999998	0.8174559794189011
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.012410050999999998	0.8174559794189011
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.012410050999999998	0.8174559794189011
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.012410050999999998	0.8174559794189011
KLEEFSTRA SYNDROME	0.012410050999999998	0.8174559794189011
#252930 MUCOPOLYSACCHARIDOSIS TYPE IIIC;;MPS IIIC; MPS3C;;SANFILIPPO SYNDROME C;;ACETYL-CoA:ALPHA-GLUCOSAMINIDE N-ACETYLTRANSFERASE DEFICIENCY	0.012410050999999998	0.8174559794189011
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.012410050999999998	0.8174559794189011
CHROMOSOME 15q13.3 MICRODELETION SYNDROME	0.012410050999999998	0.8174559794189011
#300860 MENTAL RETARDATION, X-LINKED, SYNDROMIC, NASCIMENTO TYPE; MRXSN;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 30; MRXS30	0.012410050999999998	0.8174559794189011
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.012410050999999998	0.8174559794189011
EPILEPSY-TELANGIECTASIA	0.012410050999999998	0.8174559794189011
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.012410050999999998	0.8174559794189011
#300143 MENTAL RETARDATION, X-LINKED 21; MRX21;;MENTAL RETARDATION, X-LINKED 34; MRX34	0.012410050999999998	0.8174559794189011
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.012338182	0.8127219341047556
BARATELA-SCOTT SYNDROME	0.012338182	0.8127219341047556
#615541 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 39; MRT39	0.012338182	0.8127219341047556
HOLOPROSENCEPHALY 5; HPE5	0.012338182	0.8127219341047556
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.012338182	0.8127219341047556
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.012338182	0.8127219341047556
DESBUQUOIS DYSPLASIA 2; DBQD2	0.012338182	0.8127219341047556
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3B	0.0121951	0.8032970545094007
ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D	0.0121951	0.8032970545094007
3MC SYNDROME 1	0.0121951	0.8032970545094007
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.0121951	0.8032970545094007
HYPERTELORISM, TEEBI TYPE; TBHS	0.0121951	0.8032970545094007
JOUBERT SYNDROME 3; JBTS3	0.0121951	0.8032970545094007
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.0121951	0.8032970545094007
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.0121951	0.8032970545094007
3MC SYNDROME 3	0.0121951	0.8032970545094007
MENTAL RETARDATION, X-LINKED 97; MRX97	0.011494299999999999	0.7571350242021306
TRANSALDOLASE DEFICIENCY	0.011494299999999999	0.7571350242021306
#148820 WAARDENBURG SYNDROME, TYPE 3; WS3;;WAARDENBURG SYNDROME WITH UPPER LIMB ANOMALIES;;WAARDENBURG SYNDROME, TYPE III;;KLEIN-WAARDENBURG SYNDROME	0.011494299999999999	0.7571350242021306
#190440 TRIGONOCEPHALY 1; TRIGNO1;;CRANIOSYNOSTOSIS, METOPIC	0.011494299999999999	0.7571350242021306
9q subtelomeric deletion syndrome	0.011494299999999999	0.7571350242021306
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.011494299999999999	0.7571350242021306
MCDONOUGH SYNDROME	0.011494299999999999	0.7571350242021306
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.011494299999999999	0.7571350242021306
SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME; MRXSSD	0.011494299999999999	0.7571350242021306
BOSMA ARHINIA MICROPHTHALMIA SYNDROME	0.011494299999999999	0.7571350242021306
MENTAL RETARDATION, X-LINKED 73	0.011494299999999999	0.7571350242021306
URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME; FCMSU	0.011494299999999999	0.7571350242021306
PRIMROSE SYNDROME; PRIMS	0.011494299999999999	0.7571350242021306
LICHTENSTEIN SYNDROME	0.011494299999999999	0.7571350242021306
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.001759633	0.1159078651193955
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.001759633	0.1159078651193955
IMMUNODEFICIENCY 49; IMD49	0.001759633	0.1159078651193955
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.001759633	0.1159078651193955
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.001759633	0.1159078651193955
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.001759633	0.1159078651193955
#300422 FG SYNDROME 4; FGS4MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT NYSTAGMUS, INCLUDED	0.001759633	0.1159078651193955
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.001759633	0.1159078651193955
VICI SYNDROME; VICIS	0.001759633	0.1159078651193955
WEAVER SYNDROME	0.001759633	0.1159078651193955
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.001759633	0.1159078651193955
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.001759633	0.1159078651193955
MEHMO SYNDROME; MEHMO	0.001759633	0.1159078651193955
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.001759633	0.1159078651193955
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iy; CDG1Y	0.001759633	0.1159078651193955
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.001759633	0.1159078651193955
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.001759633	0.1159078651193955
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.001759633	0.1159078651193955
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.001759633	0.1159078651193955
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.001759633	0.1159078651193955
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.001759633	0.1159078651193955
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.001759633	0.1159078651193955
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.001759633	0.1159078651193955
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.001759633	0.1159078651193955
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.001759633	0.1159078651193955
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.001759633	0.1159078651193955
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.001759633	0.1159078651193955
HEART AND BRAIN MALFORMATION SYNDROME	0.001759633	0.1159078651193955
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.001759633	0.1159078651193955
MENTAL RETARDATION, X-LINKED 90	0.001759633	0.1159078651193955
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.001759633	0.1159078651193955
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.001759633	0.1159078651193955
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.001759633	0.1159078651193955
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.001759633	0.1159078651193955
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.001759633	0.1159078651193955
TEMPLE-BARAITSER SYNDROME; TMBTS	0.001759633	0.1159078651193955
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.001759633	0.1159078651193955
ADAMS-OLIVER SYNDROME 2; AOS2	0.001759633	0.1159078651193955
MEND SYNDROME; MEND	0.001759633	0.1159078651193955
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.001759633	0.1159078651193955
#249270 THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME; TRMA;;THIAMINE METABOLISM DYSFUNCTION SYNDROME 1 (MEGALOBLASTIC ANEMIA,DIABETES MELLITUS, AND DEAFNESS TYPE); THMD1;;MEGALOBLASTIC ANEMIA, THIAMINE-RESPONSIVE, WITH DIABETES MELLITUSAND SENSORINEURAL DEAFNESS;;ROGERS SYNDROME;;THIAMINE-RESPONSIVE ANEMIA SYNDROME;;THIAMINE-RESPONSIVE MYELODYSPLASIA	0.001759633	0.1159078651193955
SCHINDLER DISEASE, TYPE I	0.001759633	0.1159078651193955
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.001759633	0.1159078651193955
OCULOECTODERMAL SYNDROME; OES	0.001759633	0.1159078651193955
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.001759633	0.1159078651193955
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.001759633	0.1159078651193955
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.001759633	0.1159078651193955
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.001759633	0.1159078651193955
GABA-TRANSAMINASE DEFICIENCY	0.001759633	0.1159078651193955
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.001759633	0.1159078651193955
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.001759633	0.1159078651193955
SALLA DISEASE	0.001759633	0.1159078651193955
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.001759633	0.1159078651193955
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.001759633	0.1159078651193955
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.001759633	0.1159078651193955
Pontine tegmental cap dysplasia	0.001759633	0.1159078651193955
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.001759633	0.1159078651193955
#614845 NEPHRONOPHTHISIS 15; NPHP15	0.001759633	0.1159078651193955
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.001759633	0.1159078651193955
LISSENCEPHALY 8; LIS8	0.001759633	0.1159078651193955
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.001759633	0.1159078651193955
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.001759633	0.1159078651193955
3-METHYLCROTONYL-CoA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.001759633	0.1159078651193955
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.001759633	0.1159078651193955
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.001759633	0.1159078651193955
#274000 THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME; TAR;;TAR SYNDROME;;CHROMOSOME 1q21.1 DELETION SYNDROME, 200-KB	0.001759633	0.1159078651193955
PHACE ASSOCIATION	0.001759633	0.1159078651193955
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.001759633	0.1159078651193955
ZTTK SYNDROME; ZTTKS	0.001759633	0.1159078651193955
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.001759633	0.1159078651193955
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.001759633	0.1159078651193955
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.001759633	0.1159078651193955
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.001759633	0.1159078651193955
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.001759633	0.1159078651193955
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.001759633	0.1159078651193955
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.001759633	0.1159078651193955
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.001759633	0.1159078651193955
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.001759633	0.1159078651193955
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.001759633	0.1159078651193955
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.001759633	0.1159078651193955
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.001759633	0.1159078651193955
ANGELMAN SYNDROME	0.001759633	0.1159078651193955
PETERS-PLUS SYNDROME; PTRPLS	0.001759633	0.1159078651193955
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.001759633	0.1159078651193955
#117550 SOTOS SYNDROME 1; SOTOS1;;SOTOS SYNDROME;;CEREBRAL GIGANTISM;;CHROMOSOME 5q35 DELETION SYNDROME	0.001759633	0.1159078651193955
RAYNAUD-CLAES SYNDROME; MRXSRC	0.001759633	0.1159078651193955
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.001759633	0.1159078651193955
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.001759633	0.1159078651193955
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.001759633	0.1159078651193955
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ix; CDG1X	0.001759633	0.1159078651193955
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.001759633	0.1159078651193955
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.001759633	0.1159078651193955
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.001759633	0.1159078651193955
#269000 SC PHOCOMELIA SYNDROME;;SC PSEUDOTHALIDOMIDE SYNDROME	0.001759633	0.1159078651193955
CATEL-MANZKE SYNDROME; CATMANS	0.001759633	0.1159078651193955
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.001759633	0.1159078651193955
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.001759633	0.1159078651193955
#612938 GROWTH RETARDATION, DEVELOPMENTAL DELAY, COARSE FACIES, AND EARLYDEATH; GDFD	0.001759633	0.1159078651193955
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.001759633	0.1159078651193955
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iw; CDG1W	0.001759633	0.1159078651193955
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.001759633	0.1159078651193955
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.001759633	0.1159078651193955
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.001759633	0.1159078651193955
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.001759633	0.1159078651193955
#301835 ARTS SYNDROME; ARTS;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARTS TYPE; MRXSARTS;;ATAXIA, FATAL X-LINKED, WITH DEAFNESS AND LOSS OF VISION;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 18; MRXS18	0.001759633	0.1159078651193955
PELIZAEUS-MERZBACHER DISEASE	0.001759633	0.1159078651193955
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.001759633	0.1159078651193955
CHROMOSOME 19p13.13 DELETION SYNDROME	0.001759633	0.1159078651193955
2,4-DIENOYL-CoA REDUCTASE DEFICIENCY; DECRD	0.001759633	0.1159078651193955
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.001759633	0.1159078651193955
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.001759633	0.1159078651193955
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.001759633	0.1159078651193955
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.001759633	0.1159078651193955
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.001759633	0.1159078651193955
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.001759633	0.1159078651193955
Pierpont syndrome	0.001759633	0.1159078651193955
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.001759633	0.1159078651193955
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.001759633	0.1159078651193955
MENTAL RETARDATION, X-LINKED 9	0.001759633	0.1159078651193955
#207800 ARGININEMIA;;ARGINASE DEFICIENCY;;HYPERARGININEMIA;;ARG1 DEFICIENCY	0.001759633	0.1159078651193955
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.001759633	0.1159078651193955
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.001759633	0.1159078651193955
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.001759633	0.1159078651193955
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.001759633	0.1159078651193955
#613668 MICROCEPHALY, POSTNATAL PROGRESSIVE, WITH SEIZURES AND BRAIN ATROPHY	0.001759633	0.1159078651193955
INFANTILE LIVER FAILURE SYNDROME 1	0.001759633	0.1159078651193955
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.001759633	0.1159078651193955
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.001759633	0.1159078651193955
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.001759633	0.1159078651193955
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.001759633	0.1159078651193955
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.001759633	0.1159078651193955
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.001759633	0.1159078651193955
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Id; CDG1D	0.001759633	0.1159078651193955
#222448 DONNAI-BARROW SYNDROME;;FACIOOCULOACOUSTICORENAL SYNDROME;;DBS/FOAR SYNDROME;;DIAPHRAGMATIC HERNIA, EXOMPHALOS, ABSENT CORPUS CALLOSUM, HYPERTELORISM,MYOPIA, SENSORINEURAL DEAFNESS, AND PROTEINURIA	0.001759633	0.1159078651193955
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.001759633	0.1159078651193955
CHROMOSOME 10Q26 DELETION SYNDROME	0.001759633	0.1159078651193955
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.001759633	0.1159078651193955
MENTAL RETARDATION, X-LINKED 72	0.001759633	0.1159078651193955
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.001759633	0.1159078651193955
#225750 AICARDI-GOUTIERES SYNDROME 1; AGS1;;AGS;;ENCEPHALOPATHY, FAMILIAL INFANTILE, WITH INTRACRANIAL CALCIFICATIONAND CHRONIC CEREBROSPINAL FLUID LYMPHOCYTOSIS;;CREE ENCEPHALITIS;;PSEUDOTOXOPLASMOSIS SYNDROMEAICARDI-GOUTIERES SYNDROME 1, AUTOSOMAL DOMINANT, INCLUDED	0.001759633	0.1159078651193955
#231050 GELEOPHYSIC DYSPLASIA 1; GPHYSD1	0.001759633	0.1159078651193955
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.001759633	0.1159078651193955
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.001759633	0.1159078651193955
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.001759633	0.1159078651193955
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.001759633	0.1159078651193955
WIEACKER-WOLFF SYNDROME	0.001759633	0.1159078651193955
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.001759633	0.1159078651193955
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.001759633	0.1159078651193955
#300831 CK SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH THIN BODY HABITUS AND CORTICALMALFORMATION	0.001759633	0.1159078651193955
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.001759633	0.1159078651193955
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.001759633	0.1159078651193955
#610829 HOLOPROSENCEPHALY 9; HPE9;;PITUITARY ANOMALIES WITH HOLOPROSENCEPHALY-LIKE FEATURES;;HOLOPROSENCEPHALY WITH MICROPHTHALMIA AND FIRST BRANCHIAL ARCH ANOMALIES	0.001759633	0.1159078651193955
#300673 ENCEPHALOPATHY, NEONATAL SEVERE, DUE TO MECP2 MUTATIONS	0.001759633	0.1159078651193955
#243500 ISOVALERIC ACIDEMIA; IVA;;ISOVALERIC ACID CoA DEHYDROGENASE DEFICIENCY;;IVD DEFICIENCY	0.001759633	0.1159078651193955
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.001759633	0.1159078651193955
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.001759633	0.1159078651193955
CHROMOSOME 1p35 DELETION SYNDROME	0.001759633	0.1159078651193955
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.001759633	0.1159078651193955
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.001759633	0.1159078651193955
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.001759633	0.1159078651193955
#300653 PHOSPHOGLYCERATE KINASE 1 DEFICIENCY;;PGK1 DEFICIENCY	0.001759633	0.1159078651193955
JOUBERT SYNDROME 30; JBTS30	0.001759633	0.1159078651193955
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ij; CDG1J	0.001759633	0.1159078651193955
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.001759633	0.1159078651193955
MENTAL RETARDATION, X-LINKED 103	0.001759633	0.1159078651193955
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.001759633	0.1159078651193955
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.001759633	0.1159078651193955
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.001759633	0.1159078651193955
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.001759633	0.1159078651193955
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.001759633	0.1159078651193955
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.001759633	0.1159078651193955
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.001759633	0.1159078651193955
HOLOPROSENCEPHALY 7	0.001759633	0.1159078651193955
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.001759633	0.1159078651193955
SULFOCYSTEINURIA	0.001759633	0.1159078651193955
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.001759633	0.1159078651193955
#136570 CHROMOSOME 16p12.1 DELETION SYNDROME, 520-KBFRAGILE SITE 16p12, INCLUDED	0.001759633	0.1159078651193955
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.001759633	0.1159078651193955
CODAS SYNDROME	0.001759633	0.1159078651193955
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.001759633	0.1159078651193955
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.001759633	0.1159078651193955
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.001759633	0.1159078651193955
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.001759633	0.1159078651193955
KAGAMI-OGATA SYNDROME	0.001759633	0.1159078651193955
LANDAU-KLEFFNER SYNDROME	0.001759633	0.1159078651193955
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.001759633	0.1159078651193955
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.001759633	0.1159078651193955
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.001759633	0.1159078651193955
#608804 LEUKODYSTROPHY, HYPOMYELINATING, 2; HLD2;;PELIZAEUS-MERZBACHER-LIKE DISEASE, 1; PMLD1	0.001759633	0.1159078651193955
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.001759633	0.1159078651193955
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.001759633	0.1159078651193955
HARTNUP DISORDER	0.001759633	0.1159078651193955
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.001759633	0.1159078651193955
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.001759633	0.1159078651193955
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.001759633	0.1159078651193955
CHROMOSOME 14q11-q22 DELETION SYNDROME	0.001759633	0.1159078651193955
PYRUVATE CARBOXYLASE DEFICIENCY	0.001759633	0.1159078651193955
KOOLEN-DE VRIES SYNDROME; KDVS	0.001759633	0.1159078651193955
GM2-GANGLIOSIDOSIS, AB VARIANT	0.001759633	0.1159078651193955
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.001759633	0.1159078651193955
611961 STEVENSON-CAREY SYNDROME	0.001759633	0.1159078651193955
#615279 CARDIOFACIOCUTANEOUS SYNDROME 3; CFC3	0.001759633	0.1159078651193955
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.001759633	0.1159078651193955
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.001759633	0.1159078651193955
LISSENCEPHALY 1; LIS1	0.001759633	0.1159078651193955
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.001759633	0.1159078651193955
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.001759633	0.1159078651193955
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.001759633	0.1159078651193955
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.001759633	0.1159078651193955
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.001759633	0.1159078651193955
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.001759633	0.1159078651193955
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.001759633	0.1159078651193955
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.001759633	0.1159078651193955
LISSENCEPHALY 4	0.001759633	0.1159078651193955
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.001759633	0.1159078651193955
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.001759633	0.1159078651193955
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.001759633	0.1159078651193955
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.001759633	0.1159078651193955
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.001759633	0.1159078651193955
NIEMANN-PICK DISEASE, TYPE C2	0.001759633	0.1159078651193955
#300886 MENTAL RETARDATION, X-LINKED, SYNDROMIC 32; MRXS32	0.001759633	0.1159078651193955
#612716 DYSTONIA, DOPA-RESPONSIVE, DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY;;SEPIAPTERIN REDUCTASE DEFICIENCY;;SPR DEFICIENCY	0.001759633	0.1159078651193955
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.001759633	0.1159078651193955
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.001759633	0.1159078651193955
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.001759633	0.1159078651193955
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.001759633	0.1159078651193955
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.001759633	0.1159078651193955
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.001759633	0.1159078651193955
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.001759633	0.1159078651193955
EMANUEL SYNDROME	0.001759633	0.1159078651193955
3-HYDROXY-3-METHYLGLUTARYL-CoA LYASE DEFICIENCY; HMGCLD	0.001759633	0.1159078651193955
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.001759633	0.1159078651193955
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.001759633	0.1159078651193955
N-ACETYLASPARTATE DEFICIENCY; NACED	0.001759633	0.1159078651193955
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.001759633	0.1159078651193955
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.001759633	0.1159078651193955
MELANOSIS, NEUROCUTANEOUS; NCMS	0.001759633	0.1159078651193955
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.001759633	0.1159078651193955
#218000 AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY; ACCPN;;CHARLEVOIX DISEASE;;ANDERMANN SYNDROME;;POLYNEUROPATHY, SENSORIMOTOR, WITH OR WITHOUT AGENESIS OF THE CORPUSCALLOSUM;;CORPUS CALLOSUM, AGENESIS OF, WITH NEURONOPATHY	0.001759633	0.1159078651193955
#612936 SPASTIC PARAPLEGIA 50, AUTOSOMAL RECESSIVE; SPG50;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3, FORMERLY; CPSQ3, FORMERLY	0.001759633	0.1159078651193955
#300845 MOYAMOYA DISEASE 4 WITH SHORT STATURE, HYPERGONADOTROPIC HYPOGONADISM,AND FACIAL DYSMORPHISM; MYMY4;;CHROMOSOME XQ28 DELETION SYNDROME, 3.4-KB;;SYNDROMIC MOYAMOYA DISEASE	0.001759633	0.1159078651193955
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIq; CDG2Q	0.001759633	0.1159078651193955
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.001759633	0.1159078651193955
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.001759633	0.1159078651193955
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.001759633	0.1159078651193955
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.001759633	0.1159078651193955
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.001759633	0.1159078651193955
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.001759633	0.1159078651193955
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.001759633	0.1159078651193955
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.001759633	0.1159078651193955
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.001759633	0.1159078651193955
PALLISTER-HALL SYNDROME	0.001759633	0.1159078651193955
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.001759633	0.1159078651193955
CHROMOSOME 16p11.2 DELETION SYNDROME, 593-KB	0.001759633	0.1159078651193955
ADAMS-OLIVER SYNDROME 1; AOS1	0.001759633	0.1159078651193955
Cerebral creatine deficiency syndrome 2	0.001759633	0.1159078651193955
#226750 KOHLSCHUTTER-TONZ SYNDROME; KTZS;;EPILEPSY AND YELLOW TEETH;;EPILEPSY, DEMENTIA, AND AMELOGENESIS IMPERFECTA;;KOHLSCHUTTER SYNDROME	0.001759633	0.1159078651193955
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.001759633	0.1159078651193955
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.001759633	0.1159078651193955
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.001759633	0.1159078651193955
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.001759633	0.1159078651193955
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.001759633	0.1159078651193955
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.001759633	0.1159078651193955
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.001759633	0.1159078651193955
HYPEREKPLEXIA 4; HKPX4	0.001759633	0.1159078651193955
AICARDI-GOUTIERES SYNDROME 7	0.001759633	0.1159078651193955
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.001759633	0.1159078651193955
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.001759633	0.1159078651193955
#604317 MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT CORTICALMALFORMATIONS; MCPH2	0.001759633	0.1159078651193955
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.001759633	0.1159078651193955
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.001759633	0.1159078651193955
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.001759633	0.1159078651193955
PETTIGREW SYNDROME	0.001759633	0.1159078651193955
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.001759633	0.1159078651193955
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.001759633	0.1159078651193955
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.001759633	0.1159078651193955
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.001759633	0.1159078651193955
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.001759633	0.1159078651193955
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.001759633	0.1159078651193955
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.001759633	0.1159078651193955
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.001759633	0.1159078651193955
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.001759633	0.1159078651193955
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.001759633	0.1159078651193955
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.001759633	0.1159078651193955
MIRAGE SYNDROME; MIRAGE	0.001759633	0.1159078651193955
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.001759633	0.1159078651193955
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.001759633	0.1159078651193955
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.001759633	0.1159078651193955
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.001759633	0.1159078651193955
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.001759633	0.1159078651193955
CHROMOSOME 1q41-q42 DELETION SYNDROME	0.001759633	0.1159078651193955
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.001759633	0.1159078651193955
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.001759633	0.1159078651193955
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.001759633	0.1159078651193955
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE; MAHCC	0.001759633	0.1159078651193955
#158350 COWDEN SYNDROME 1; CWS1;;CS; CD;;MULTIPLE HAMARTOMA SYNDROME; MHAMDYSPLASTIC GANGLIOCYTOMA OF THE CEREBELLUM, INCLUDED;;CEREBELLOPARENCHYMAL DISORDER VI, INCLUDED; CPD6, INCLUDED;;CEREBELLAR GRANULE CELL HYPERTROPHY AND MEGALENCEPHALY, INCLUDED;;LHERMITTE-DUCLOS DISEASE, INCLUDED; LDD, INCLUDED;;PROTEUS-LIKE SYNDROME, INCLUDED	0.001759633	0.1159078651193955
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.001759633	0.1159078651193955
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.001759633	0.1159078651193955
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.001759633	0.1159078651193955
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.001759633	0.1159078651193955
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.001759633	0.1159078651193955
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.001759633	0.1159078651193955
GRISCELLI SYNDROME, TYPE 1	0.001759633	0.1159078651193955
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.001759633	0.1159078651193955
#613744 SPASTIC PARAPLEGIA 51, AUTOSOMAL RECESSIVE; SPG51;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 4, FORMERLY; CPSQ4, FORMERLY	0.001759633	0.1159078651193955
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.001759633	0.1159078651193955
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.001759633	0.1159078651193955
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.001759633	0.1159078651193955
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.001759633	0.1159078651193955
Helsmoortel-van der Aa syndrome	0.001759633	0.1159078651193955
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.001759633	0.1159078651193955
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.001759633	0.1159078651193955
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.001759633	0.1159078651193955
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iu; CDG1U	0.001759633	0.1159078651193955
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.001759633	0.1159078651193955
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.001759633	0.1159078651193955
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.001759633	0.1159078651193955
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.001759633	0.1159078651193955
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.001759633	0.1159078651193955
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.001759633	0.1159078651193955
HOLOPROSENCEPHALY 1; HPE1	0.001759633	0.1159078651193955
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.001759633	0.1159078651193955
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.001759633	0.1159078651193955
BAND HETEROTOPIA; BH	0.001759633	0.1159078651193955
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.001759633	0.1159078651193955
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.001759633	0.1159078651193955
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.001759633	0.1159078651193955
CITRULLINEMIA, CLASSIC	0.001759633	0.1159078651193955
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.001759633	0.1159078651193955
POTOCKI-LUPSKI SYNDROME	0.001759633	0.1159078651193955
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.001759633	0.1159078651193955
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.001759633	0.1159078651193955
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.001759633	0.1159078651193955
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.001759633	0.1159078651193955
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.001759633	0.1159078651193955
RECOMBINANT CHROMOSOME 8 SYNDROME	0.001759633	0.1159078651193955
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.001759633	0.1159078651193955
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.001759633	0.1159078651193955
#614322 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 12; SCAR12;;SPINOCEREBELLAR ATAXIA WITH MENTAL RETARDATION AND EPILEPSY	0.001759633	0.1159078651193955
#611718 HYPOMAGNESEMIA 4, RENAL; HOMG4;;HYPOMAGNESEMIA, RENAL, NORMOCALCIURIC	0.001759633	0.1159078651193955
#608027 PONTOCEREBELLAR HYPOPLASIA, TYPE 3; PCH3;;CEREBELLAR ATROPHY WITH PROGRESSIVE MICROCEPHALY; CLAM;;PCH WITH OPTIC ATROPHY	0.001759633	0.1159078651193955
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ik; CDG1K	0.001759633	0.1159078651193955
PEHO SYNDROME; PEHO	0.001759633	0.1159078651193955
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.001759633	0.1159078651193955
GRACILE BONE DYSPLASIA; GCLEB	0.001759633	0.1159078651193955
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.001759633	0.1159078651193955
PRADER-WILLI SYNDROME; PWS	0.001759633	0.1159078651193955
LUSCAN-LUMISH SYNDROME; LLS	0.001759633	0.1159078651193955
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.001759633	0.1159078651193955
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.001759633	0.1159078651193955
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.001759633	0.1159078651193955
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.001759633	0.1159078651193955
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIl; CDG2L	0.001759633	0.1159078651193955
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.001759633	0.1159078651193955
INFANTILE SIALIC ACID STORAGE DISEASE	0.001759633	0.1159078651193955
CHROMOSOME 5Q12 DELETION SYNDROME	0.001759633	0.1159078651193955
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.001759633	0.1159078651193955
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.001759633	0.1159078651193955
#606777 GLUT1 DEFICIENCY SYNDROME 1; GLUT1DS1;;GLUCOSE TRANSPORT DEFECT, BLOOD-BRAIN BARRIERGLUT1 DEFICIENCY SYNDROME 1, AUTOSOMAL RECESSIVE, INCLUDED	0.001759633	0.1159078651193955
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.001759633	0.1159078651193955
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.001759633	0.1159078651193955
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ii; CDG1I	0.001759633	0.1159078651193955
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.001759633	0.1159078651193955
CHROMOSOME 16p13.2 DELETION SYNDROME	0.001759633	0.1159078651193955
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.001759633	0.1159078651193955
KETOADIPICACIDURIA	0.001759633	0.1159078651193955
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.001759633	0.1159078651193955
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.001759633	0.1159078651193955
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.001759633	0.1159078651193955
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.001759633	0.1159078651193955
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.001759633	0.1159078651193955
FOLATE MALABSORPTION, HEREDITARY	0.001759633	0.1159078651193955
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.001759633	0.1159078651193955
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.001759633	0.1159078651193955
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.001759633	0.1159078651193955
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.001759633	0.1159078651193955
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.001759633	0.1159078651193955
CHROMOSOME 19q13.11 DELETION SYNDROME, PROXIMAL	0.001759633	0.1159078651193955
WEBB-DATTANI SYNDROME; WEDAS	0.001759633	0.1159078651193955
C SYNDROME	0.001759633	0.1159078651193955
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.001759633	0.1159078651193955
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.001759633	0.1159078651193955
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.001759633	0.1159078651193955
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.001759633	0.1159078651193955
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.001759633	0.1159078651193955
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.001759633	0.1159078651193955
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.001759633	0.1159078651193955
#613180 POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.001759633	0.1159078651193955
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.001759633	0.1159078651193955
MENTAL RETARDATION, X-LINKED 104; MRX104	0.001759633	0.1159078651193955
#311250 ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO;;ORNITHINE CARBAMOYLTRANSFERASE DEFICIENCY;;OTC DEFICIENCYVALPROATE SENSITIVITY, INCLUDED	0.001759633	0.1159078651193955
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.001759633	0.1159078651193955
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ip; CDG1P	0.001759633	0.1159078651193955
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia; CDG1A	0.001759633	0.1159078651193955
#305450 OPITZ-KAVEGGIA SYNDROME; OKS;;FG SYNDROME 1; FGS1;;FG SYNDROME; FGS;;MENTAL RETARDATION, LARGE HEAD, IMPERFORATE ANUS, CONGENITAL HYPOTONIA,AND PARTIAL AGENESIS OF CORPUS CALLOSUM;;KELLER SYNDROME	0.001759633	0.1159078651193955
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.001759633	0.1159078651193955
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.001759633	0.1159078651193955
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.001759633	0.1159078651193955
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.001759633	0.1159078651193955
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.001759633	0.1159078651193955
COACH SYNDROME	0.001759633	0.1159078651193955
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.001759633	0.1159078651193955
SHUKLA-VERNON SYNDROME; SHUVER	0.001759633	0.1159078651193955
#613730 HEMORRHAGIC DESTRUCTION OF THE BRAIN, SUBEPENDYMAL CALCIFICATION,AND CATARACTS; HDBSCC	0.001759633	0.1159078651193955
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.001759633	0.1159078651193955
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.001759633	0.1159078651193955
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.001759633	0.1159078651193955
3-METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.001759633	0.1159078651193955
#614483 PORENCEPHALY 2; POREN2	0.001759633	0.1159078651193955
DIGEORGE SYNDROME; DGS	0.001759633	0.1159078651193955
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.001759633	0.1159078651193955
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.001759633	0.1159078651193955
#236250 HOMOCYSTINURIA DUE TO DEFICIENCY OF N(5,10)-METHYLENETETRAHYDROFOLATEREDUCTASE ACTIVITY;;METHYLENETETRAHYDROFOLATE REDUCTASE DEFICIENCY;;MTHFR DEFICIENCYMTHFR DEFICIENCY, THERMOLABILE TYPE, INCLUDED	0.001759633	0.1159078651193955
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.001759633	0.1159078651193955
TIMOTHY SYNDROME; TS	0.001759633	0.1159078651193955
CHROMOSOME 22q13 DUPLICATION SYNDROME	0.001759633	0.1159078651193955
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.001759633	0.1159078651193955
GAUCHER DISEASE, TYPE II	0.001759633	0.1159078651193955
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.001759633	0.1159078651193955
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.001759633	0.1159078651193955
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.001759633	0.1159078651193955
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.001759633	0.1159078651193955
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.001759633	0.1159078651193955
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.001759633	0.1159078651193955
Muenke syndrome	0.001759633	0.1159078651193955
HOLOPROSENCEPHALY 2; HPE2	0.001759633	0.1159078651193955
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.001759633	0.1159078651193955
#602398 DESMOSTEROLOSIS	0.001759633	0.1159078651193955
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.001759633	0.1159078651193955
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.001759633	0.1159078651193955
#613657 D-2-@HYDROXYGLUTARIC ACIDURIA 2;;D2HGA2	0.001759633	0.1159078651193955
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.001759633	0.1159078651193955
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.001759633	0.1159078651193955
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.001759633	0.1159078651193955
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.001759633	0.1159078651193955
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.001759633	0.1159078651193955
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Il; CDG1L	0.001759633	0.1159078651193955
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.001759633	0.1159078651193955
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.001759633	0.1159078651193955
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.001759633	0.1159078651193955
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.001759633	0.1159078651193955
#251290 BAND-LIKE CALCIFICATION WITH SIMPLIFIED GYRATION AND POLYMICROGYRIA;BLCPMG;;PSEUDO-TORCH SYNDROME	0.001759633	0.1159078651193955
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.001759633	0.1159078651193955
ARGININOSUCCINIC ACIDURIA	0.001759633	0.1159078651193955
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.001759633	0.1159078651193955
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.001759633	0.1159078651193955
MENTAL RETARDATION, X-LINKED 88	0.001759633	0.1159078651193955
Xq28 (MECP2) duplication	0.001759633	0.1159078651193955
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.001759633	0.1159078651193955
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.001759633	0.1159078651193955
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.001759633	0.1159078651193955
#237300 CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY, HYPERAMMONEMIA DUE TO;;CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY;;CPS I DEFICIENCY	0.001759633	0.1159078651193955
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.001759633	0.1159078651193955
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.001759633	0.1159078651193955
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.001759633	0.1159078651193955
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.001759633	0.1159078651193955
METHYLMALONIC ACIDURIA, CBLA TYPE	0.001759633	0.1159078651193955
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.001759633	0.1159078651193955
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.001759633	0.1159078651193955
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.001759633	0.1159078651193955
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.001759633	0.1159078651193955
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.001759633	0.1159078651193955
#300894 NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 5; NBIA5;;BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION; BPAN;;STATIC ENCEPHALOPATHY OF CHILDHOOD WITH NEURODEGENERATION IN ADULTHOOD;SENDA	0.001759633	0.1159078651193955
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.001759633	0.1159078651193955
#220120 D-GLYCERIC ACIDURIA;;D-GLYCERIC ACIDEMIA;;GLYCERATE KINASE DEFICIENCY	0.001759633	0.1159078651193955
PROPIONIC ACIDEMIA	0.001759633	0.1159078651193955
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.001759633	0.1159078651193955
#615182 COMBINED D-2- AND L-2-HYDROXYGLUTARIC ACIDURIA; D2L2AD	0.001759633	0.1159078651193955
#245400 MITOCHONDRIAL DNA DEPLETION SYNDROME 9 (ENCEPHALOMYOPATHIC TYPE WITHMETHYLMALONIC ACIDURIA); MTDPS9;;LACTIC ACIDOSIS, FATAL INFANTILE, FORMERLY	0.001759633	0.1159078651193955
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.001759633	0.1159078651193955
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.001759633	0.1159078651193955
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.001759633	0.1159078651193955
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.001759633	0.1159078651193955
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.001759633	0.1159078651193955
MENTAL RETARDATION, X-LINKED 91; MRX91	0.001759633	0.1159078651193955
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.001759633	0.1159078651193955
ADENYLOSUCCINASE DEFICIENCY	0.001759633	0.1159078651193955
WAISMAN SYNDROME; WSMN	0.001759633	0.1159078651193955
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIf; CDG2F	0.001759633	0.1159078651193955
#603387 MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME;MPPH;;MEGALENCEPHALY, POLYMICROGYRIA, MEGA CORPUS CALLOSUM SYNDROME;;MEG-PMG-MEGACC SYNDROME;;MEGALENCEPHALY, MEGA CORPUS CALLOSUM, AND COMPLETE LACK OF MOTOR DEVELOPMENT	0.001759633	0.1159078651193955
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.001759633	0.1159078651193955
LEIGH SYNDROME; LS	0.001759633	0.1159078651193955
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.001759633	0.1159078651193955
GLYCEROL KINASE DEFICIENCY; GKD	0.001759633	0.1159078651193955
ELEJALDE DISEASE	0.001759633	0.1159078651193955
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ic; CDG1C	0.001759633	0.1159078651193955
MENTAL RETARDATION, X-LINKED 101; MRX101	0.001759633	0.1159078651193955
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.001759633	0.1159078651193955
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.001759633	0.1159078651193955
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000915751	0.060320955216770514
IMMUNODEFICIENCY 47	0.000915751	0.060320955216770514
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.000915751	0.060320955216770514
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.000915751	0.060320955216770514
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.000915751	0.060320955216770514
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.000915751	0.060320955216770514
GLUTARIC ACIDEMIA I; GA1	0.000915751	0.060320955216770514
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.000915751	0.060320955216770514
GLUTAMINE DEFICIENCY, CONGENITAL	0.000915751	0.060320955216770514
ACROCALLOSAL SYNDROME; ACLS	0.000915751	0.060320955216770514
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000915751	0.060320955216770514
CRANIOSYNOSTOSIS 2	0.000915751	0.060320955216770514
#300534 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CLAES-JENSEN TYPE; MRXSCJ;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, JARID1C-RELATED; MRXSJ	0.000915751	0.060320955216770514
GITELMAN SYNDROME	0.000915751	0.060320955216770514
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.000915751	0.060320955216770514
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.000915751	0.060320955216770514
GLYCINE ENCEPHALOPATHY; GCE	0.000915751	0.060320955216770514
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.000915751	0.060320955216770514
KUFOR-RAKEB SYNDROME	0.000915751	0.060320955216770514
#218600 BALLER-GEROLD SYNDROME; BGS;;CRANIOSYNOSTOSIS WITH RADIAL DEFECTS;;CRANIOSYNOSTOSIS-RADIAL APLASIA SYNDROME	0.000915751	0.060320955216770514
MEGALENCEPHALY WITH DYSMYELINATION	0.000915751	0.060320955216770514
ADAMS-OLIVER SYNDROME 5; AOS5	0.000915751	0.060320955216770514
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.000915751	0.060320955216770514
#240900 HYPOINSULINEMIC HYPOGLYCEMIA WITH HEMIHYPERTROPHY; HIHGHH	0.000915751	0.060320955216770514
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.000915751	0.060320955216770514
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000915751	0.060320955216770514
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.000915751	0.060320955216770514
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.000915751	0.060320955216770514
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.000915751	0.060320955216770514
#158900 FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1; FSHD1;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1;;FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; FSHD; FMD;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1A; FSHD1A;;LANDOUZY-DEJERINE MUSCULAR DYSTROPHYFACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY, INFANTILE, INCLUDED;;FACIOSCAPULOHUMERAL DYSTROPHY WITH SENSORINEURAL HEARING LOSS ANDTORTUOSITY OF RETINAL ARTERIOLES, INCLUDED	0.000915751	0.060320955216770514
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.000915751	0.060320955216770514
PITT-HOPKINS SYNDROME	0.000915751	0.060320955216770514
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000915751	0.060320955216770514
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.000915751	0.060320955216770514
#610539 GAUCHER DISEASE, ATYPICAL, DUE TO SAPOSIN C DEFICIENCY	0.000915751	0.060320955216770514
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.000915751	0.060320955216770514
NEUROFIBROMATOSIS, TYPE I	0.000915751	0.060320955216770514
#176000 PORPHYRIA, ACUTE INTERMITTENT;;AIP;;PORPHYRIA, SWEDISH TYPE;;PORPHOBILINOGEN DEAMINASE DEFICIENCY;;PBGD DEFICIENCY;;UROPORPHYRINOGEN SYNTHASE DEFICIENCY;;UPS DEFICIENCYPORPHYRIA, ACUTE INTERMITTENT, NONERYTHROID VARIANT, INCLUDED;;PORPHYRIA, CHESTER TYPE, INCLUDED; PORC, INCLUDED	0.000915751	0.060320955216770514
#603285 CEREBRAL CAVERNOUS MALFORMATIONS 3; CCM3	0.000915751	0.060320955216770514
Fabry disease	0.000915751	0.060320955216770514
#256731 CEROID LIPOFUSCINOSIS, NEURONAL, 5; CLN5;;CEROID LIPOFUSCINOSIS, NEURONAL, 5, VARIABLE AGE AT ONSETNEURONAL CEROID LIPOFUSCINOSIS, LATE INFANTILE, FINNISH VARIANT, INCLUDED;;FINNISH vLINCL, INCLUDED	0.000915751	0.060320955216770514
OROFACIODIGITAL SYNDROME I; OFD1	0.000915751	0.060320955216770514
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.000915751	0.060320955216770514
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.000915751	0.060320955216770514
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.000915751	0.060320955216770514
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.000915751	0.060320955216770514
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.000915751	0.060320955216770514
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000915751	0.060320955216770514
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.000915751	0.060320955216770514
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000915751	0.060320955216770514
SUPRABULBAR PARESIS, CONGENITAL	0.000915751	0.060320955216770514
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.000915751	0.060320955216770514
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.000915751	0.060320955216770514
#236792 L-2-HYDROXYGLUTARIC ACIDURIA;;L-2-HYDROXYGLUTARIC ACIDEMIA	0.000915751	0.060320955216770514
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.000915751	0.060320955216770514
#608033 ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 3; IIAE3;;ENCEPHALOPATHY, ACUTE NECROTIZING, SUSCEPTIBILITY TO; ANE	0.000915751	0.060320955216770514
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.000915751	0.060320955216770514
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.000915751	0.060320955216770514
#177980 PTERYGIA, MENTAL RETARDATION, AND DISTINCTIVE CRANIOFACIAL FEATURES;;HASPESLAGH SYNDROME	0.000915751	0.060320955216770514
#612285 JOUBERT SYNDROME 9; JBTS9JOUBERT SYNDROME 9/15, DIGENIC, INCLUDED	0.000915751	0.060320955216770514
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.000915751	0.060320955216770514
#602541 MUSCULAR DYSTROPHY, CONGENITAL, MEGACONIAL TYPE; MDCMC;;MUSCULAR DYSTROPHY, CONGENITAL, WITH MITOCHONDRIAL STRUCTURAL ABNORMALITIES	0.000915751	0.060320955216770514
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.000915751	0.060320955216770514
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.000915751	0.060320955216770514
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.000915751	0.060320955216770514
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.000915751	0.060320955216770514
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.000915751	0.060320955216770514
AUTISM, SUSCEPTIBILITY TO, 18	0.000915751	0.060320955216770514
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.000915751	0.060320955216770514
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.000915751	0.060320955216770514
#612580 MENTAL RETARDATION, AUTOSOMAL DOMINANT 3; MRD3	0.000915751	0.060320955216770514
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.000915751	0.060320955216770514
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.000915751	0.060320955216770514
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.000915751	0.060320955216770514
NEURAMINIDASE DEFICIENCY	0.000915751	0.060320955216770514
#103580 PSEUDOHYPOPARATHYROIDISM, TYPE IA; PHP1A;;PHP IA;;ALBRIGHT HEREDITARY OSTEODYSTROPHY WITH MULTIPLE HORMONE RESISTANCE	0.000915751	0.060320955216770514
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.000915751	0.060320955216770514
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.000915751	0.060320955216770514
#614650 COENZYME Q10 DEFICIENCY, PRIMARY, 6; COQ10D6	0.000915751	0.060320955216770514
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.000915751	0.060320955216770514
THREONINEMIA	0.000915751	0.060320955216770514
TAY-SACHS DISEASE; TSD	0.000915751	0.060320955216770514
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.000915751	0.060320955216770514
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.000915751	0.060320955216770514
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.000915751	0.060320955216770514
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.000915751	0.060320955216770514
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.000915751	0.060320955216770514
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000915751	0.060320955216770514
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.000915751	0.060320955216770514
#309801 MICROPHTHALMIA, SYNDROMIC 7; MCOPS7;;MICROPHTHALMIA WITH LINEAR SKIN DEFECTS; MLS;;MICROPHTHALMIA, DERMAL APLASIA, AND SCLEROCORNEA;;MIDAS SYNDROME	0.000915751	0.060320955216770514
#613150 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYEANOMALIES), TYPE A, 2; MDDGA2;;WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, POMT2-RELATED	0.000915751	0.060320955216770514
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.000915751	0.060320955216770514
ATKIN-FLAITZ SYNDROME	0.000915751	0.060320955216770514
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.000915751	0.060320955216770514
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.000915751	0.060320955216770514
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000915751	0.060320955216770514
CROUZON SYNDROME	0.000915751	0.060320955216770514
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.000915751	0.060320955216770514
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000915751	0.060320955216770514
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.000915751	0.060320955216770514
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.000915751	0.060320955216770514
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.000915751	0.060320955216770514
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.000915751	0.060320955216770514
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.000915751	0.060320955216770514
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.000915751	0.060320955216770514
#612462 PSEUDOHYPOPARATHYROIDISM, TYPE IC; PHP1C;;PHP IC	0.000915751	0.060320955216770514
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.000915751	0.060320955216770514
#607136 SPINOCEREBELLAR ATAXIA 17; SCA17;;HUNTINGTON DISEASE-LIKE 4; HDL4	0.000915751	0.060320955216770514
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.000915751	0.060320955216770514
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.000915751	0.060320955216770514
COWDEN SYNDROME 6; CWS6	0.000915751	0.060320955216770514
#615752 POLYMICROGYRIA, BILATERAL PERISYLVIAN, AUTOSOMAL RECESSIVE; BPPR ;;PMGR	0.000915751	0.060320955216770514
DARIER-WHITE DISEASE; DAR	0.000915751	0.060320955216770514
#310600 NORRIE DISEASE; ND;;ATROPHIA BULBORUM HEREDITARIA;;EPISKOPI BLINDNESS	0.000915751	0.060320955216770514
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.000915751	0.060320955216770514
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.000915751	0.060320955216770514
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.000915751	0.060320955216770514
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000915751	0.060320955216770514
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.000915751	0.060320955216770514
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.000915751	0.060320955216770514
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000915751	0.060320955216770514
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.000915751	0.060320955216770514
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.000915751	0.060320955216770514
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.000915751	0.060320955216770514
ASPARTYLGLUCOSAMINURIA; AGU	0.000915751	0.060320955216770514
GLUTATHIONE SYNTHETASE DEFICIENCY	0.000915751	0.060320955216770514
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.000915751	0.060320955216770514
IMMUNODEFICIENCY 37; IMD37	0.000915751	0.060320955216770514
MENTAL RETARDATION, FRA12A TYPE	0.000915751	0.060320955216770514
Angelman syndrome (Type 1)	0.000915751	0.060320955216770514
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.000915751	0.060320955216770514
LISSENCEPHALY, X-LINKED, 1; LISX1	0.000915751	0.060320955216770514
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.000915751	0.060320955216770514
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.000915751	0.060320955216770514
PAPILLOMA OF CHOROID PLEXUS	0.000915751	0.060320955216770514
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.000915751	0.060320955216770514
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.000915751	0.060320955216770514
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.000915751	0.060320955216770514
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIj; CDG2J	0.000915751	0.060320955216770514
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.000915751	0.060320955216770514
CYCLIC VOMITING SYNDROME	0.000915751	0.060320955216770514
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000915751	0.060320955216770514
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.000915751	0.060320955216770514
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.000915751	0.060320955216770514
MENTAL RETARDATION, X-LINKED 100	0.000915751	0.060320955216770514
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.000915751	0.060320955216770514
CHROMOSOME 18Q DELETION SYNDROME	0.000915751	0.060320955216770514
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.000915751	0.060320955216770514
CHROMOSOME 15q11-q13 DUPLICATION SYNDROME	0.000915751	0.060320955216770514
PARIETAL FORAMINA	0.000915751	0.060320955216770514
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.000915751	0.060320955216770514
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.000915751	0.060320955216770514
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.000915751	0.060320955216770514
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.000915751	0.060320955216770514
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.000915751	0.060320955216770514
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000915751	0.060320955216770514
FLYNN-AIRD SYNDROME	0.000915751	0.060320955216770514
#309510 PARTINGTON X-LINKED MENTAL RETARDATION SYNDROME; PRTS;;PARTINGTON SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 1; MRXS1;;MENTAL RETARDATION, X-LINKED, WITH DYSTONIC MOVEMENTS, ATAXIA, ANDSEIZURES;;MENTAL RETARDATION, X-LINKED 36; MRX36	0.000915751	0.060320955216770514
#614923 BRANCHED-CHAIN KETOACID DEHYDROGENASE KINASE DEFICIENCY; BCKDKD;;BCKDK DEFICIENCY	0.000915751	0.060320955216770514
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, cblX TYPE	0.000915751	0.060320955216770514
FILIPPI SYNDROME; FLPIS	0.000915751	0.060320955216770514
GRISCELLI SYNDROME, TYPE 2; GS2	0.000915751	0.060320955216770514
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.000915751	0.060320955216770514
#244460 KENNY-CAFFEY SYNDROME, TYPE 1; KCS1;;KCS;;KENNY-CAFFEY SYNDROME, AUTOSOMAL RECESSIVE	0.000915751	0.060320955216770514
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.000915751	0.060320955216770514
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000915751	0.060320955216770514
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.000915751	0.060320955216770514
XYLOSIDASE DEFICIENCY	0.000915751	0.060320955216770514
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.000915751	0.060320955216770514
OCULODENTODIGITAL DYSPLASIA; ODDD	0.000915751	0.060320955216770514
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.000915751	0.060320955216770514
Angelman syndrome (Type 2)	0.000915751	0.060320955216770514
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.000915751	0.060320955216770514
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.000915751	0.060320955216770514
MECKEL SYNDROME, TYPE 10; MKS10	0.000915751	0.060320955216770514
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.000915751	0.060320955216770514
#248250 HYPOMAGNESEMIA 3, RENAL; HOMG3;;HYPOMAGNESEMIA, PRIMARY, DUE TO DEFECT IN RENAL TUBULAR TRANSPORTOF MAGNESIUM;;HYPOMAGNESEMIA, ISOLATED RENAL;;HYPOMAGNESEMIA, FAMILIAL, WITH HYPERCALCIURIA AND NEPHROCALCINOSISHYPERCALCIURIA, CHILDHOOD, SELF-LIMITING, INCLUDED	0.000915751	0.060320955216770514
#300607 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 8; EIEE8;;HYPEREKPLEXIA AND EPILEPSY	0.000915751	0.060320955216770514
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.000915751	0.060320955216770514
#612951 LEUKOENCEPHALOPATHY, CYSTIC, WITHOUT MEGALENCEPHALY	0.000915751	0.060320955216770514
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.000915751	0.060320955216770514
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.000915751	0.060320955216770514
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.000915751	0.060320955216770514
THYROCEREBRORETINAL SYNDROME	0.000915751	0.060320955216770514
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.000915751	0.060320955216770514
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.000915751	0.060320955216770514
INCONTINENTIA PIGMENTI; IP	0.000915751	0.060320955216770514
#119540 CLEFT PALATE, ISOLATED; CPI;;CLEFT PALATE; CPCLEFT PALATE, ISOLATED, AND MENTAL RETARDATION, INCLUDED	0.000915751	0.060320955216770514
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.000915751	0.060320955216770514
PREECLAMPSIA/ECLAMPSIA 1	0.000915751	0.060320955216770514
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.000915751	0.060320955216770514
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.000915751	0.060320955216770514
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.000915751	0.060320955216770514
PSEUDO-TORCH SYNDROME 2	0.000915751	0.060320955216770514
#309520 LUJAN-FRYNS SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH MARFANOID HABITUS	0.000915751	0.060320955216770514
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.000915751	0.060320955216770514
MENTAL RETARDATION, X-LINKED 82	0.000915751	0.060320955216770514
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.000915751	0.060320955216770514
HYPOPHOSPHATASIA, CHILDHOOD	0.000915751	0.060320955216770514
2q33.1 deletion syndrome	0.000915751	0.060320955216770514
#125310 CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTSAND LEUKOENCEPHALOPATHY; CADASIL;;DEMENTIA, HEREDITARY MULTI-INFARCT TYPE;;CASIL	0.000915751	0.060320955216770514
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.000915751	0.060320955216770514
#202200 GLUCOCORTICOID DEFICIENCY 1; GCCD1;;FAMILIAL GLUCOCORTICOID DEFICIENCY 1; FGD1;;ADRENAL UNRESPONSIVENESS TO ACTH;;ACTH RESISTANCE	0.000915751	0.060320955216770514
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.000915751	0.060320955216770514
ZUNICH NEUROECTODERMAL SYNDROME	0.000915751	0.060320955216770514
EPILEPSY, READING	0.000915751	0.060320955216770514
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.000915751	0.060320955216770514
LISSENCEPHALY 5; LIS5	0.000915751	0.060320955216770514
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.000915751	0.060320955216770514
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.000915751	0.060320955216770514
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.000915751	0.060320955216770514
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.000915751	0.060320955216770514
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.000915751	0.060320955216770514
RETINAL DEGENERATION AND EPILEPSY	0.000915751	0.060320955216770514
COWDEN SYNDROME 5; CWS5	0.000915751	0.060320955216770514
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.000915751	0.060320955216770514
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.000915751	0.060320955216770514
KIFAFA SEIZURE DISORDER	0.000915751	0.060320955216770514
MENTAL RETARDATION, X-LINKED 14	0.000915751	0.060320955216770514
PAPILLORENAL SYNDROME	0.000915751	0.060320955216770514
#214500 CHEDIAK-HIGASHI SYNDROME; CHS	0.000915751	0.060320955216770514
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.000915751	0.060320955216770514
#614399 MYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET;EMARDDMYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET,MILD VARIANT, INCLUDED	0.000915751	0.060320955216770514
HYPERPROLINEMIA, TYPE II	0.000915751	0.060320955216770514
KEARNS-SAYRE SYNDROME; KSS	0.000915751	0.060320955216770514
AUTISM	0.000915751	0.060320955216770514
KAPUR-TORIELLO SYNDROME	0.000915751	0.060320955216770514
#187300 TELANGIECTASIA, HEREDITARY HEMORRHAGIC, OF RENDU, OSLER, AND WEBER;HHT;;OSLER-RENDU-WEBER DISEASE;;ORW DISEASETELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 1, INCLUDED; HHT1, INCLUDED	0.000915751	0.060320955216770514
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.000915751	0.060320955216770514
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.000915751	0.060320955216770514
ALZHEIMER DISEASE 3; AD	0.000915751	0.060320955216770514
DIAMINOPENTANURIA	0.000915751	0.060320955216770514
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.000915751	0.060320955216770514
HYPOPARATHYROIDISM, X-LINKED	0.000915751	0.060320955216770514
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.000915751	0.060320955216770514
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.000915751	0.060320955216770514
#229600 FRUCTOSE INTOLERANCE, HEREDITARY;;FRUCTOSEMIA;;FRUCTOSE-1-PHOSPHATE ALDOLASE DEFICIENCY;;FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE B DEFICIENCY;;ALDOLASE B DEFICIENCY;;ALDOB DEFICIENCY	0.000915751	0.060320955216770514
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.000915751	0.060320955216770514
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.000915751	0.060320955216770514
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.000915751	0.060320955216770514
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.000915751	0.060320955216770514
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.000915751	0.060320955216770514
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIe; CDG2E	0.000915751	0.060320955216770514
PERRAULT SYNDROME 5; PRLTS5	0.000915751	0.060320955216770514
LISSENCEPHALY, X-LINKED, 2	0.000915751	0.060320955216770514
#235400 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1; AHUS1;;AHUS, SUSCEPTIBILITY TO, 1HEMOLYTIC UREMIC SYNDROME, TYPICAL, INCLUDED	0.000915751	0.060320955216770514
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.000915751	0.060320955216770514
#615663 WARBURG MICRO SYNDROME 4; WARBM4	0.000915751	0.060320955216770514
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.000915751	0.060320955216770514
CROME SYNDROME	0.000915751	0.060320955216770514
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.000915751	0.060320955216770514
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.000915751	0.060320955216770514
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.000915751	0.060320955216770514
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.000915751	0.060320955216770514
#215100 RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 1; RCDP1;;PEROXISOME BIOGENESIS DISORDER 9; PBD9;;CHONDRODYSPLASIA PUNCTATA, RHIZOMELIC FORM; CDPR;;CHONDRODYSTROPHIA CALCIFICANS PUNCTATA	0.000915751	0.060320955216770514
#608836 CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LETHAL NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, ANTENATAL;;CPT II DEFICIENCY, LETHAL NEONATAL;;CPT2 DEFICIENCY, LETHAL NEONATAL	0.000915751	0.060320955216770514
FRYNS SYNDROME; FRNS	0.000915751	0.060320955216770514
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.000915751	0.060320955216770514
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.000915751	0.060320955216770514
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.000915751	0.060320955216770514
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.000915751	0.060320955216770514
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.000915751	0.060320955216770514
#252011 MITOCHONDRIAL COMPLEX II DEFICIENCY;;SUCCINATE CoQ REDUCTASE DEFICIENCY	0.000915751	0.060320955216770514
#612438 LEUKODYSTROPHY, HYPOMYELINATING, 6; HLD6;;LEUKODYSTROPHY, HYPOMYELINATING, WITH ATROPHY OF THE BASAL GANGLIAAND CEREBELLUM; HABC	0.000915751	0.060320955216770514
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.000915751	0.060320955216770514
#520000 DIABETES AND DEAFNESS, MATERNALLY INHERITED; MIDD;;DIABETES-DEAFNESS SYNDROME, MATERNALLY TRANSMITTED;;BALLINGER-WALLACE SYNDROME;;DIABETES MELLITUS, TYPE II, WITH DEAFNESS;;NONINSULIN-DEPENDENT DIABETES MELLITUS WITH DEAFNESS;;NIDDM WITH DEAFNESS	0.000915751	0.060320955216770514
CEREBELLOPARENCHYMAL DISORDER II	0.000915751	0.060320955216770514
MENTAL RETARDATION, X-LINKED 102	0.000915751	0.060320955216770514
PACHYGYRIA, FRONTOTEMPORAL	0.000915751	0.060320955216770514
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.000915751	0.060320955216770514
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.000915751	0.060320955216770514
#612475 CHROMOSOME 1q21.1 DUPLICATION SYNDROME	0.000915751	0.060320955216770514
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.000915751	0.060320955216770514
HYPOADRENOCORTICISM, FAMILIAL	0.000915751	0.060320955216770514
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000915751	0.060320955216770514
Adrenoleukodystrophy	0.000915751	0.060320955216770514
Wolf-Hirschhorn Syndrome	0.000915751	0.060320955216770514
HYPERLEUCINE-ISOLEUCINEMIA	0.000915751	0.060320955216770514
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.000915751	0.060320955216770514
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.000915751	0.060320955216770514
#264470 PEROXISOMAL ACYL-CoA OXIDASE DEFICIENCY;;STRAIGHT-CHAIN ACYL-CoA OXIDASE DEFICIENCY;;PSEUDONEONATAL ADRENOLEUKODYSTROPHY	0.000915751	0.060320955216770514
RAMON SYNDROME	0.000915751	0.060320955216770514
#603516 SPINOCEREBELLAR ATAXIA 10; SCA10	0.000915751	0.060320955216770514
224250 DYSMYELINATION WITH JAUNDICE	0.000915751	0.060320955216770514
GURRIERI SYNDROME	0.000915751	0.060320955216770514
FOUNTAIN SYNDROME	0.000915751	0.060320955216770514
#223360 DOPAMINE BETA-HYDROXYLASE DEFICIENCY, CONGENITAL;;NOREPINEPHRINE DEFICIENCY;;NORADRENALINE DEFICIENCY	0.000915751	0.060320955216770514
#615937 MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 2;MPPH2	0.000915751	0.060320955216770514
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.000915751	0.060320955216770514
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.000915751	0.060320955216770514
VISCERAL STEATOSIS, CONGENITAL	0.000915751	0.060320955216770514
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.000915751	0.060320955216770514
KNOBLOCH SYNDROME 1; KNO1	0.000915751	0.060320955216770514
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000915751	0.060320955216770514
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.000915751	0.060320955216770514
HYPER-BETA-ALANINEMIA	0.000915751	0.060320955216770514
GAUCHER DISEASE, TYPE IIIC	0.000915751	0.060320955216770514
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.000915751	0.060320955216770514
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.000915751	0.060320955216770514
SNEDDON SYNDROME	0.000915751	0.060320955216770514
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.000915751	0.060320955216770514
WARBURG MICRO SYNDROME 3; WARBM3	0.000915751	0.060320955216770514
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.000915751	0.060320955216770514
MAPLE SYRUP URINE DISEASE; MSUD	0.000915751	0.060320955216770514
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.000915751	0.060320955216770514
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.000915751	0.060320955216770514
#300049 HETEROTOPIA, PERIVENTRICULAR, X-LINKED DOMINANT;;HETEROTOPIA, FAMILIAL NODULAR;;PERIVENTRICULAR NODULAR HETEROTOPIA 1; PVNH1;;NODULAR HETEROTOPIA, BILATERAL PERIVENTRICULAR; NHBP; BPNHHETEROTOPIA, PERIVENTRICULAR NODULAR, WITH FRONTOMETAPHYSEAL DYSPLASIA,INCLUDED	0.000915751	0.060320955216770514
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.000915751	0.060320955216770514
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.000915751	0.060320955216770514
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.000915751	0.060320955216770514
INFANTILE LIVER FAILURE SYNDROME 2	0.000915751	0.060320955216770514
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.000915751	0.060320955216770514
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.000915751	0.060320955216770514
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.000915751	0.060320955216770514
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.000915751	0.060320955216770514
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.000915751	0.060320955216770514
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.000915751	0.060320955216770514
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.000915751	0.060320955216770514
#300337 HYPOMELANOSIS OF ITO; HMI;;INCONTINENTIA PIGMENTI ACHROMIANS; IPA;;ITO HYPOMELANOSIS; ITO;;INCONTINENTIA PIGMENTI, TYPE I, FORMERLY; IP1, FORMERLY	0.000915751	0.060320955216770514
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.000915751	0.060320955216770514
COCKAYNE SYNDROME A; CSA	0.000915751	0.060320955216770514
#612199 CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS; CRMCC;;COATS PLUS SYNDROME	0.000915751	0.060320955216770514
METACHROMATIC LEUKODYSTROPHY	0.000915751	0.060320955216770514
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.000915751	0.060320955216770514
#611755 LEBER CONGENITAL AMAUROSIS 10; LCA10	0.000915751	0.060320955216770514
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.000915751	0.060320955216770514
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.000915751	0.060320955216770514
1p36 microdeletion syndrome	0.000915751	0.060320955216770514
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.000915751	0.060320955216770514
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.000915751	0.060320955216770514
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.000915751	0.060320955216770514
LISSENCEPHALY 3; LIS3	0.000915751	0.060320955216770514
HUNTINGTON DISEASE; HD	0.000915751	0.060320955216770514
#604213 CHUDLEY-MCCULLOUGH SYNDROME; CMCS;;DEAFNESS, SENSORINEURAL, WITH PARTIAL AGENESIS OF THE CORPUS CALLOSUMAND ARACHNOID CYSTS;;DEAFNESS, AUTOSOMAL RECESSIVE 82; DFNB82	0.000915751	0.060320955216770514
SPINOCEREBELLAR ATAXIA 47; SCA47	0.000915751	0.060320955216770514
#116860 CEREBRAL CAVERNOUS MALFORMATIONS; CCM;;CAVERNOUS ANGIOMA, FAMILIAL;;CAVERNOUS ANGIOMATOUS MALFORMATIONS; CAM;;CEREBRAL CAPILLARY MALFORMATIONSCEREBRAL CAVERNOUS MALFORMATIONS 1, INCLUDED; CCM1, INCLUDED;;CAVERNOUS MALFORMATIONS OF CNS AND RETINA, INCLUDED;;HYPERKERATOTIC CUTANEOUS CAPILLARY-VENOUS MALFORMATIONS ASSOCIATEDWITH CEREBRAL CAPILLARY MALFORMATIONS, INCLUDED	0.000915751	0.060320955216770514
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.000915751	0.060320955216770514
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.000915751	0.060320955216770514
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.000915751	0.060320955216770514
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.000915751	0.060320955216770514
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.000915751	0.060320955216770514
COPPER DEFICIENCY, FAMILIAL BENIGN	0.000915751	0.060320955216770514
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.000915751	0.060320955216770514
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.000915751	0.060320955216770514
SUDDEN CARDIAC FAILURE, INFANTILE	0.000915751	0.060320955216770514
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.000915751	0.060320955216770514
MICROPHTHALMIA, SYNDROMIC 1	0.000915751	0.060320955216770514
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.000915751	0.060320955216770514
LATHOSTEROLOSIS	0.000915751	0.060320955216770514
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.000915751	0.060320955216770514
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.000915751	0.060320955216770514
#300558 MENTAL RETARDATION, X-LINKED 30; MRX30;;MENTAL RETARDATION, X-LINKED 47; MRX47	0.000915751	0.060320955216770514
HYPERLYSINEMIA, TYPE I	0.000915751	0.060320955216770514
CHOREOATHETOSIS, FAMILIAL INVERTED	0.000915751	0.060320955216770514
HHHH SYNDROME	0.000915751	0.060320955216770514
KRABBE DISEASE	0.000915751	0.060320955216770514
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.000915751	0.060320955216770514
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.000915751	0.060320955216770514
FRUCTOSE AND GALACTOSE INTOLERANCE	0.000915751	0.060320955216770514
LOWE OCULOCEREBRORENAL SYNDROME	0.000915751	0.060320955216770514
EPISODIC ATAXIA, TYPE 6	0.000915751	0.060320955216770514
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.000915751	0.060320955216770514
ALEXANDER DISEASE	0.000915751	0.060320955216770514
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.000915751	0.060320955216770514
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.000915751	0.060320955216770514
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.000915751	0.060320955216770514
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.000915751	0.060320955216770514
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.000915751	0.060320955216770514
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.000915751	0.060320955216770514
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.000915751	0.060320955216770514
RETINITIS PIGMENTOSA 59; RP59	0.000915751	0.060320955216770514
FRAGILE X MENTAL RETARDATION SYNDROME	0.000915751	0.060320955216770514
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.000915751	0.060320955216770514
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.000915751	0.060320955216770514
#605375 EPILEPSY, NOCTURNAL FRONTAL LOBE, 3; ENFL3	0.000915751	0.060320955216770514
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.000915751	0.060320955216770514
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.000915751	0.060320955216770514
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000915751	0.060320955216770514
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.000915751	0.060320955216770514
PERRAULT SYNDROME 3	0.000915751	0.060320955216770514
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.000915751	0.060320955216770514
#613707 LEOPARD SYNDROME 3; LPRD3	0.000915751	0.060320955216770514
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.000915751	0.060320955216770514
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.000915751	0.060320955216770514
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.000915751	0.060320955216770514
GLYCOGEN STORAGE DISEASE 0, LIVER	0.000915751	0.060320955216770514
MARDEN-WALKER SYNDROME	0.000915751	0.060320955216770514
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.000915751	0.060320955216770514
MENTAL RETARDATION, X-LINKED 1	0.000915751	0.060320955216770514
#276710 TYROSINEMIA, TYPE III; TYRSN3;;4-@HYDROXYPHENYLPYRUVIC ACID OXIDASE DEFICIENCY;;4-@HYDROXYPHENYLPYRUVATE DIOXYGENASE DEFICIENCY	0.000915751	0.060320955216770514
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.000915751	0.060320955216770514
ICHTHYOSIS AND MALE HYPOGONADISM	0.000915751	0.060320955216770514
SECKEL SYNDROME 7; SCKL7	0.000915751	0.060320955216770514
HYPOPHOSPHATASIA, INFANTILE	0.000915751	0.060320955216770514
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.000915751	0.060320955216770514
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.000915751	0.060320955216770514
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.000915751	0.060320955216770514
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.000915751	0.060320955216770514
KEUTEL SYNDROME; KTLS	0.000915751	0.060320955216770514
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.000915751	0.060320955216770514
SJOGREN-LARSSON SYNDROME; SLS	0.000915751	0.060320955216770514
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.000915751	0.060320955216770514
#222300 WOLFRAM SYNDROME 1; WFS1;;WFS;;DIABETES INSIPIDUS AND MELLITUS WITH OPTIC ATROPHY AND DEAFNESS; DIDMOAD	0.000915751	0.060320955216770514
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.000915751	0.060320955216770514
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.000915751	0.060320955216770514
RETT SYNDROME; RTT	0.000915751	0.060320955216770514
#222748 DIHYDROPYRIMIDINASE DEFICIENCY;;DIHYDROPYRIMIDINURIA;;DPYS DEFICIENCY;;DPH DEFICIENCY	0.000915751	0.060320955216770514
OCULOCEREBROCUTANEOUS SYNDROME	0.000915751	0.060320955216770514
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.000915751	0.060320955216770514
ACTH DEFICIENCY, ISOLATED; IAD	0.000915751	0.060320955216770514
#604004 MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 1; MLC1;;VACUOLATING MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS;;LVM;;VL;;LEUKOENCEPHALOPATHY WITH SWELLING AND CYSTS;;VAN DER KNAAP DISEASE	0.000915751	0.060320955216770514
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.000915751	0.060320955216770514
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.000915751	0.060320955216770514
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.000915751	0.060320955216770514
MUCOPOLYSACCHARIDOSIS, TYPE II	0.000915751	0.060320955216770514
NOONAN SYNDROME 7; NS7	0.000915751	0.060320955216770514
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.000915751	0.060320955216770514
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.000915751	0.060320955216770514
EPILEPSY, BENIGN OCCIPITAL	0.000915751	0.060320955216770514
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.000915751	0.060320955216770514
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.000915751	0.060320955216770514
#141500 MIGRAINE, FAMILIAL HEMIPLEGIC, 1; FHM1;;FHM;;MHP1MIGRAINE, FAMILIAL HEMIPLEGIC 1, WITH PROGRESSIVE CEREBELLAR ATAXIA,INCLUDED;;MIGRAINE, SPORADIC HEMIPLEGIC, INCLUDED	0.000915751	0.060320955216770514
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.000915751	0.060320955216770514
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.000915751	0.060320955216770514
#609060 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 1; COXPD1;;HEPATOENCEPHALOPATHY, EARLY FATAL PROGRESSIVE	0.000915751	0.060320955216770514
#236600 HYDROCEPHALUS, NONSYNDROMIC, AUTOSOMAL RECESSIVE 1; HYC1;;HYDROCEPHALY;;VENTRICULOMEGALY	0.000915751	0.060320955216770514
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.000915751	0.060320955216770514
GAUCHER DISEASE, PERINATAL LETHAL	0.000915751	0.060320955216770514
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.000915751	0.060320955216770514
BRANCHIOOCULOFACIAL SYNDROME	0.000915751	0.060320955216770514
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.000915751	0.060320955216770514
RETT SYNDROME, CONGENITAL VARIANT	0.000915751	0.060320955216770514
PHENYLKETONURIA	0.000915751	0.060320955216770514
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000915751	0.060320955216770514
SECKEL SYNDROME 1; SCKL1	0.000915751	0.060320955216770514
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.000915751	0.060320955216770514
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.000915751	0.060320955216770514
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000915751	0.060320955216770514
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.000915751	0.060320955216770514
311450 PALLISTER W SYNDROME;;W SYNDROME	0.000915751	0.060320955216770514
#615705 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 15; SCAR15;;SALIH ATAXIA	0.000915751	0.060320955216770514
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.000915751	0.060320955216770514
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.000915751	0.060320955216770514
HYPOMAGNESEMIA 2, RENAL	0.000915751	0.060320955216770514
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.000915751	0.060320955216770514
#200150 CHOREOACANTHOCYTOSIS; CHAC;;LEVINE-CRITCHLEY SYNDROME;;ACANTHOCYTOSIS WITH NEUROLOGIC DISORDER;;NEUROACANTHOCYTOSIS;;CHOREA-ACANTHOCYTOSIS	0.000915751	0.060320955216770514
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.000915751	0.060320955216770514
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.000915751	0.060320955216770514
CLARK-BARAITSER SYNDROME	0.000915751	0.060320955216770514
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.000843882	0.05558690990262499
JOUBERT SYNDROME 25	0.000843882	0.05558690990262499
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.000843882	0.05558690990262499
TYSHCHENKO SYNDROME	0.000843882	0.05558690990262499
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.000843882	0.05558690990262499
CULLER-JONES SYNDROME; CJS	0.000843882	0.05558690990262499
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.000843882	0.05558690990262499
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.000843882	0.05558690990262499
Mental retardation, autosomal dominant 21	0.000843882	0.05558690990262499
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.000843882	0.05558690990262499
MEVALONIC ACIDURIA; MEVA	0.000843882	0.05558690990262499
SECKEL SYNDROME 9; SCKL9	0.000843882	0.05558690990262499
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.000843882	0.05558690990262499
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.000843882	0.05558690990262499
#300555 DENT DISEASE 2	0.000843882	0.05558690990262499
#615033 SPASTIC PARAPLEGIA 54, AUTOSOMAL RECESSIVE; SPG54	0.000843882	0.05558690990262499
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ig; CDG1G	0.000843882	0.05558690990262499
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.000843882	0.05558690990262499
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.000843882	0.05558690990262499
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.000843882	0.05558690990262499
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.000843882	0.05558690990262499
BARDET-BIEDL SYNDROME 3; BBS3	0.000843882	0.05558690990262499
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.000843882	0.05558690990262499
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.000843882	0.05558690990262499
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.000843882	0.05558690990262499
CURRARINO SYNDROME	0.000843882	0.05558690990262499
JOUBERT SYNDROME 24	0.000843882	0.05558690990262499
GABRIELE-DE VRIES SYNDROME; GADEVS	0.000843882	0.05558690990262499
#611936 CHROMOSOME 3q29 DUPLICATION SYNDROME;;MICRODUPLICATION 3q29 SYNDROME	0.000843882	0.05558690990262499
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.000843882	0.05558690990262499
REVESZ SYNDROME	0.000843882	0.05558690990262499
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.000843882	0.05558690990262499
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.000843882	0.05558690990262499
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.000843882	0.05558690990262499
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.000843882	0.05558690990262499
FRONTOOCULAR SYNDROME	0.000843882	0.05558690990262499
Aarskog-Scott syndrome	0.000843882	0.05558690990262499
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.000843882	0.05558690990262499
#600638 FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3A, WITH OR WITHOUT EXTRAOCULARINVOLVEMENT; CFEOM3A;;FEOM3 LOCUS	0.000843882	0.05558690990262499
MACROCEPHALY/AUTISM SYNDROME	0.000843882	0.05558690990262499
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.000843882	0.05558690990262499
HARTSFIELD SYNDROME; HRTFDS	0.000843882	0.05558690990262499
NOONAN SYNDROME 2; NS2	0.000843882	0.05558690990262499
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.000843882	0.05558690990262499
COFFIN-SIRIS SYNDROME 6; CSS6	0.000843882	0.05558690990262499
Cerebral creatine deficiency syndrome 3	0.000843882	0.05558690990262499
CRANIOTELENCEPHALIC DYSPLASIA	0.000843882	0.05558690990262499
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.000843882	0.05558690990262499
RAHMAN SYNDROME	0.000843882	0.05558690990262499
#300123 MENTAL RETARDATION, X-LINKED, WITH PANHYPOPITUITARISMMENTAL RETARDATION, X-LINKED, WITH ISOLATED GROWTH HORMONE DEFICIENCY,INCLUDED; MRGH, INCLUDED	0.000843882	0.05558690990262499
COSTELLO SYNDROME; CSTLO	0.000843882	0.05558690990262499
MUCOLIPIDOSIS IV; ML4	0.000843882	0.05558690990262499
BARDET-BIEDL SYNDROME 14; BBS14	0.000843882	0.05558690990262499
GENITOPATELLAR SYNDROME; GTPTS	0.000843882	0.05558690990262499
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.000843882	0.05558690990262499
Leukotriene C4 synthase deficiency	0.000843882	0.05558690990262499
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.000843882	0.05558690990262499
HADZISELIMOVIC SYNDROME	0.000843882	0.05558690990262499
#609528 CEREBRAL DYSGENESIS, NEUROPATHY, ICHTHYOSIS, AND PALMOPLANTAR KERATODERMASYNDROME;;CEDNIK SYNDROME	0.000843882	0.05558690990262499
#614213 NEUROPATHY, HEREDITARY SENSORY, TYPE IIC; HSN2C	0.000843882	0.05558690990262499
JOUBERT SYNDROME 15	0.000843882	0.05558690990262499
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.000843882	0.05558690990262499
LOWRY-MACLEAN SYNDROME	0.000843882	0.05558690990262499
NOONAN SYNDROME 3; NS3	0.000843882	0.05558690990262499
#614402 MICROPHTHALMIA, SYNDROMIC 11; MCOPS11	0.000843882	0.05558690990262499
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.000843882	0.05558690990262499
RETINITIS PIGMENTOSA 80; RP80	0.000843882	0.05558690990262499
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000843882	0.05558690990262499
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.000843882	0.05558690990262499
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.000843882	0.05558690990262499
JOUBERT SYNDROME 28	0.000843882	0.05558690990262499
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.000843882	0.05558690990262499
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.000843882	0.05558690990262499
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.000843882	0.05558690990262499
#609425 CHROMOSOME 3q29 DELETION SYNDROME;;MICRODELETION 3q29 SYNDROME	0.000843882	0.05558690990262499
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.000843882	0.05558690990262499
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.000843882	0.05558690990262499
JOUBERT SYNDROME 27	0.000843882	0.05558690990262499
JOUBERT SYNDROME 32; JBTS32	0.000843882	0.05558690990262499
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.000843882	0.05558690990262499
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.000843882	0.05558690990262499
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.000843882	0.05558690990262499
ROIFMAN SYNDROME; RFMN	0.000843882	0.05558690990262499
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.000843882	0.05558690990262499
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.000843882	0.05558690990262499
#610758 CEREBROOCULOFACIOSKELETAL SYNDROME 4; COFS4	0.000843882	0.05558690990262499
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.000843882	0.05558690990262499
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.000843882	0.05558690990262499
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.000843882	0.05558690990262499
MITOCHONDRIAL SHORT-CHAIN ENOYL-CoA HYDRATASE 1 DEFICIENCY; ECHS1D	0.000843882	0.05558690990262499
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.000843882	0.05558690990262499
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.000843882	0.05558690990262499
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.000843882	0.05558690990262499
#608443 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 3; MRT3	0.000843882	0.05558690990262499
NOONAN SYNDROME 5; NS5	0.000843882	0.05558690990262499
POPOV-CHANG SYNDROME; POPCHAS	0.000843882	0.05558690990262499
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.000843882	0.05558690990262499
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.000843882	0.05558690990262499
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.000843882	0.05558690990262499
#614728 SECKEL SYNDROME 6; SCKL6	0.000843882	0.05558690990262499
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.000843882	0.05558690990262499
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000843882	0.05558690990262499
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.000843882	0.05558690990262499
BARDET-BIEDL SYNDROME 17; BBS17	0.000843882	0.05558690990262499
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.000843882	0.05558690990262499
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.000843882	0.05558690990262499
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.000843882	0.05558690990262499
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.000843882	0.05558690990262499
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000843882	0.05558690990262499
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.000843882	0.05558690990262499
JOUBERT SYNDROME 7	0.000843882	0.05558690990262499
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.000843882	0.05558690990262499
TOWNES-BROCKS SYNDROME 1; TBS1	0.000843882	0.05558690990262499
#610915 OSTEOGENESIS IMPERFECTA, TYPE VIII; OI8;;OI, TYPE VIII	0.000843882	0.05558690990262499
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.000843882	0.05558690990262499
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.000843882	0.05558690990262499
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.000843882	0.05558690990262499
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.000843882	0.05558690990262499
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000843882	0.05558690990262499
LAMB-SHAFFER SYNDROME	0.000843882	0.05558690990262499
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.000843882	0.05558690990262499
#609054 FANCONI ANEMIA, COMPLEMENTATION GROUP J; FANCJ	0.000843882	0.05558690990262499
CHROMOSOME 15q25 DELETION SYNDROME	0.000843882	0.05558690990262499
#615665 JOUBERT SYNDROME 22; JBTS22	0.000843882	0.05558690990262499
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.000843882	0.05558690990262499
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.000843882	0.05558690990262499
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.000843882	0.05558690990262499
LIG4 SYNDROME	0.000843882	0.05558690990262499
SEPTOOPTIC DYSPLASIA	0.000843882	0.05558690990262499
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.000843882	0.05558690990262499
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.000843882	0.05558690990262499
CURRY-JONES SYNDROME	0.000843882	0.05558690990262499
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.000843882	0.05558690990262499
XIA-GIBBS SYNDROME	0.000843882	0.05558690990262499
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.000843882	0.05558690990262499
JOUBERT SYNDROME 31; JBTS31	0.000843882	0.05558690990262499
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.000843882	0.05558690990262499
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.000843882	0.05558690990262499
YOU-HOOVER-FONG SYNDROME; YHFS	0.000843882	0.05558690990262499
#615432 SPECIFIC LANGUAGE IMPAIRMENT 5; SLI5	0.000843882	0.05558690990262499
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.000843882	0.05558690990262499
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.000843882	0.05558690990262499
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.000843882	0.05558690990262499
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.000843882	0.05558690990262499
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.000843882	0.05558690990262499
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000843882	0.05558690990262499
WARSAW BREAKAGE SYNDROME; WABS	0.000843882	0.05558690990262499
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000843882	0.05558690990262499
#613603 CHROMOSOME 4q32.1-q32.2 TRIPLICATION SYNDROME	0.000843882	0.05558690990262499
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.000843882	0.05558690990262499
#612626 CHROMOSOME 15q26-qter DELETION SYNDROME;;DRAYER SYNDROME	0.000843882	0.05558690990262499
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.000843882	0.05558690990262499
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.000843882	0.05558690990262499
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.000843882	0.05558690990262499
#275900 SPASTIC PARAPLEGIA 20, AUTOSOMAL RECESSIVE; SPG20;;TROYER SYNDROME;;SPASTIC PARAPARESIS, CHILDHOOD-ONSET, WITH DISTAL MUSCLE WASTING;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, TROYER TYPE	0.000843882	0.05558690990262499
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.000843882	0.05558690990262499
OROFACIODIGITAL SYNDROME XIV; OFD14	0.000843882	0.05558690990262499
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 1; CEMCOX1	0.000843882	0.05558690990262499
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.000843882	0.05558690990262499
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.000843882	0.05558690990262499
OROFACIODIGITAL SYNDROME VI	0.000843882	0.05558690990262499
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.000843882	0.05558690990262499
JOUBERT SYNDROME 6	0.000843882	0.05558690990262499
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.000843882	0.05558690990262499
Bardet-Biedl syndrome 2	0.000843882	0.05558690990262499
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.000843882	0.05558690990262499
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.000843882	0.05558690990262499
#610168 LOEYS-DIETZ SYNDROME 2; LDS2;;AORTIC ANEURYSM, FAMILIAL THORACIC 3; AAT3;;MARFAN SYNDROME, TYPE II, FORMERLY	0.000843882	0.05558690990262499
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.000843882	0.05558690990262499
ALAZAMI SYNDROME; ALAZS	0.000843882	0.05558690990262499
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.000843882	0.05558690990262499
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.000843882	0.05558690990262499
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.000843882	0.05558690990262499
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.000843882	0.05558690990262499
ALSTROM SYNDROME; ALMS	0.000843882	0.05558690990262499
#272200 MULTIPLE SULFATASE DEFICIENCY; MSD;;MUCOSULFATIDOSIS;;SULFATIDOSIS, JUVENILE, AUSTIN TYPE	0.000843882	0.05558690990262499
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.000843882	0.05558690990262499
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.000843882	0.05558690990262499
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.000843882	0.05558690990262499
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.000843882	0.05558690990262499
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.000843882	0.05558690990262499
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.000843882	0.05558690990262499
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.000843882	0.05558690990262499
BAKER-GORDON SYNDROME; BAGOS	0.000843882	0.05558690990262499
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.000843882	0.05558690990262499
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.000843882	0.05558690990262499
OPTIC ATROPHY 11; OPA11	0.000843882	0.05558690990262499
#615401 IMMUNODEFICIENCY 8; IMD8	0.000843882	0.05558690990262499
ARIMA SYNDROME	0.000843882	0.05558690990262499
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.000843882	0.05558690990262499
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.000843882	0.05558690990262499
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.000843882	0.05558690990262499
FRIAS SYNDROME	0.000843882	0.05558690990262499
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.000843882	0.05558690990262499
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000843882	0.05558690990262499
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.000843882	0.05558690990262499
CRANIOSYNOSTOSIS 6; CRS6	0.000843882	0.05558690990262499
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.000843882	0.05558690990262499
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.000843882	0.05558690990262499
MICROPHTHALMIA, SYNDROMIC 3	0.000843882	0.05558690990262499
#267000 PERLMAN SYNDROME; PRLMNS;;RENAL HAMARTOMAS, NEPHROBLASTOMATOSIS, AND FETAL GIGANTISM;;NEPHROBLASTOMATOSIS, FETAL ASCITES, MACROSOMIA, AND WILMS TUMOR	0.000843882	0.05558690990262499
MECKEL SYNDROME 13; MKS13	0.000843882	0.05558690990262499
#227810 FANCONI-BICKEL SYNDROME; FBS;;HEPATORENAL GLYCOGENOSIS WITH RENAL FANCONI SYNDROME;;HEPATIC GLYCOGENOSIS WITH FANCONI NEPHROPATHY;;HEPATIC GLYCOGENOSIS WITH AMINO ACIDURIA AND GLUCOSURIA;;FANCONI SYNDROME WITH INTESTINAL MALABSORPTION AND GALACTOSE INTOLERANCE;;PSEUDO-PHLORIZIN DIABETES;;GLYCOGENOSIS, FANCONI TYPE;;GLYCOGEN STORAGE DISEASE XI	0.000843882	0.05558690990262499
AUSTRALIA ANTIGEN	0.000843882	0.05558690990262499
#615066 OSTEOGENESIS IMPERFECTA, TYPE XIV; OI14 ;;OI, TYPE XIV	0.000843882	0.05558690990262499
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.000843882	0.05558690990262499
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.000843882	0.05558690990262499
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.000843882	0.05558690990262499
AICARDI-GOUTIERES SYNDROME 5	0.000843882	0.05558690990262499
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.000843882	0.05558690990262499
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.000843882	0.05558690990262499
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.000843882	0.05558690990262499
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.000843882	0.05558690990262499
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.000843882	0.05558690990262499
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.000843882	0.05558690990262499
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.000843882	0.05558690990262499
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000843882	0.05558690990262499
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.000843882	0.05558690990262499
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.000843882	0.05558690990262499
PEROXISOME BIOGENESIS DISORDER 6B	0.000843882	0.05558690990262499
MENTAL RETARDATION, X-LINKED 99	0.000843882	0.05558690990262499
#610185 CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME2; CAMRQ2;;CEREBELLAR ATAXIA AND MENTAL RETARDATION WITH OR WITHOUT QUADRUPEDALLOCOMOTION 2	0.000843882	0.05558690990262499
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.000843882	0.05558690990262499
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.000843882	0.05558690990262499
OROTIC ACIDURIA	0.000843882	0.05558690990262499
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.000843882	0.05558690990262499
STEEL SYNDROME; STLS	0.000843882	0.05558690990262499
#615583 VERHEIJ SYNDROME; VRJS;;CHROMOSOME 8q24.3 DELETION SYNDROME	0.000843882	0.05558690990262499
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.000843882	0.05558690990262499
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.000843882	0.05558690990262499
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.000843882	0.05558690990262499
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.000843882	0.05558690990262499
BARDET-BIEDL SYNDROME 16; BBS16	0.000843882	0.05558690990262499
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.000843882	0.05558690990262499
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.000843882	0.05558690990262499
HOLOPROSENCEPHALY 3; HPE3	0.000843882	0.05558690990262499
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.000843882	0.05558690990262499
#303110 CHOROIDEREMIA, DEAFNESS, AND MENTAL RETARDATION;;CHROMOSOME Xq21 DELETION SYNDROME	0.000843882	0.05558690990262499
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000843882	0.05558690990262499
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.000843882	0.05558690990262499
CHROMOSOME 18P DELETION SYNDROME	0.000843882	0.05558690990262499
HYPOTONIA-CYSTINURIA SYNDROME	0.000843882	0.05558690990262499
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.000843882	0.05558690990262499
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.000843882	0.05558690990262499
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.000843882	0.05558690990262499
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.000843882	0.05558690990262499
AICARDI-GOUTIERES SYNDROME 6	0.000843882	0.05558690990262499
SWEENEY-COX SYNDROME; SWCOS	0.000843882	0.05558690990262499
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.000843882	0.05558690990262499
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000843882	0.05558690990262499
LARSEN-LIKE SYNDROME	0.000843882	0.05558690990262499
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.000843882	0.05558690990262499
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.000843882	0.05558690990262499
%300712 CRANIOFACIOSKELETAL SYNDROME	0.000843882	0.05558690990262499
METHYLMALONIC ACIDURIA, CBLB TYPE	0.000843882	0.05558690990262499
OROFACIODIGITAL SYNDROME VIII; OFD8	0.000843882	0.05558690990262499
SPINOCEREBELLAR ATAXIA 5; SCA5	0.000843882	0.05558690990262499
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.000843882	0.05558690990262499
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.000843882	0.05558690990262499
CHROMOSOME Xq27.3-q28 DUPLICATION SYNDROME	0.000843882	0.05558690990262499
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.000843882	0.05558690990262499
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.000843882	0.05558690990262499
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.000843882	0.05558690990262499
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.000843882	0.05558690990262499
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.000843882	0.05558690990262499
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.000843882	0.05558690990262499
#170100 PROLIDASE DEFICIENCY	0.000843882	0.05558690990262499
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.000843882	0.05558690990262499
ADAMS-OLIVER SYNDROME 3; AOS3	0.000843882	0.05558690990262499
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000843882	0.05558690990262499
RICHARDS-RUNDLE SYNDROME; RRNS	0.000843882	0.05558690990262499
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.000843882	0.05558690990262499
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.000843882	0.05558690990262499
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.000843882	0.05558690990262499
TONNE-KALSCHEUER SYNDROME; TOKAS	0.000843882	0.05558690990262499
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.000843882	0.05558690990262499
HYDROCEPHALUS, NORMAL-PRESSURE	0.000843882	0.05558690990262499
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.000843882	0.05558690990262499
BARDET-BIEDL SYNDROME 13; BBS13	0.000843882	0.05558690990262499
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000843882	0.05558690990262499
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.000843882	0.05558690990262499
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.000843882	0.05558690990262499
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.000843882	0.05558690990262499
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.000843882	0.05558690990262499
DIAMOND-BLACKFAN ANEMIA 5	0.000843882	0.05558690990262499
BARDET-BIEDL SYNDROME 8; BBS8	0.000843882	0.05558690990262499
PEROXISOME BIOGENESIS DISORDER 5B	0.000843882	0.05558690990262499
HYDROXYKYNURENINURIA	0.000843882	0.05558690990262499
JOUBERT SYNDROME 26	0.000843882	0.05558690990262499
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.000843882	0.05558690990262499
PELLAGRA-LIKE SYNDROME	0.000843882	0.05558690990262499
JOUBERT SYNDROME 10	0.000843882	0.05558690990262499
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.000843882	0.05558690990262499
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.000843882	0.05558690990262499
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.000843882	0.05558690990262499
#613752 HYPERMETHIONINEMIA WITH S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.000843882	0.05558690990262499
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.000843882	0.05558690990262499
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.000843882	0.05558690990262499
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.000843882	0.05558690990262499
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.000843882	0.05558690990262499
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.000843882	0.05558690990262499
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.000843882	0.05558690990262499
MARINESCO-SJOGREN SYNDROME; MSS	0.000843882	0.05558690990262499
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.000843882	0.05558690990262499
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000843882	0.05558690990262499
NIEMANN-PICK DISEASE, TYPE A	0.000843882	0.05558690990262499
#613641 CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE B; CMTRIB;;CHARCOT-MARIE-TOOTH NEUROPATHY, RECESSIVE INTERMEDIATE B; RI-CMTB	0.000843882	0.05558690990262499
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.000843882	0.05558690990262499
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.000843882	0.05558690990262499
PEROXISOME BIOGENESIS DISORDER 3B	0.000843882	0.05558690990262499
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000843882	0.05558690990262499
HURLER SYNDROME	0.000843882	0.05558690990262499
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.000843882	0.05558690990262499
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.000843882	0.05558690990262499
JOUBERT SYNDROME 8	0.000843882	0.05558690990262499
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.000843882	0.05558690990262499
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.000843882	0.05558690990262499
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.000843882	0.05558690990262499
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.000843882	0.05558690990262499
#231550 ACHALASIA-ADDISONIANISM-ALACRIMA SYNDROME; AAAS;;TRIPLE-A SYNDROME;;ALACRIMA-ACHALASIA-ADRENAL INSUFFICIENCY NEUROLOGIC DISORDER;;GLUCOCORTICOID DEFICIENCY AND ACHALASIA;;ALLGROVE SYNDROME;;ADDISONIAN-ACHALASIA SYNDROME;;HYPOADRENALISM WITH ACHALASIA;;ALACRIMA-ACHALASIA-ADDISONIANISM;;ACTH-RESISTANT ADRENAL INSUFFICIENCY, ACHALASIA AND ALACRIMAACHALASIA-ALACRIMA SYNDROME, INCLUDED	0.000843882	0.05558690990262499
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.000843882	0.05558690990262499
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.000843882	0.05558690990262499
#604804 MICROCEPHALY 3, PRIMARY, AUTOSOMAL RECESSIVE; MCPH3	0.000843882	0.05558690990262499
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.000843882	0.05558690990262499
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.000843882	0.05558690990262499
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.000843882	0.05558690990262499
#614970 JOUBERT SYNDROME 20; JBTS20	0.000843882	0.05558690990262499
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.000843882	0.05558690990262499
JOUBERT SYNDROME 23; JBTS23	0.000843882	0.05558690990262499
MENTAL RETARDATION, X-LINKED 107; MRX107	0.000843882	0.05558690990262499
JOUBERT SYNDROME 33; JBTS33	0.000843882	0.05558690990262499
OROFACIODIGITAL SYNDROME XVI; OFD16	0.000843882	0.05558690990262499
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.000843882	0.05558690990262499
JOUBERT SYNDROME 17; JBTS17	0.000843882	0.05558690990262499
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.000843882	0.05558690990262499
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.000843882	0.05558690990262499
GALACTOSE EPIMERASE DEFICIENCY	0.000843882	0.05558690990262499
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.000843882	0.05558690990262499
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.000843882	0.05558690990262499
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000843882	0.05558690990262499
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.000843882	0.05558690990262499
#268310 ROBINOW SYNDROME, AUTOSOMAL RECESSIVE; RRS;;COSTOVERTEBRAL SEGMENTATION DEFECT WITH MESOMELIA, FORMERLY;;COVESDEM SYNDROME, FORMERLYROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH APLASIA/HYPOPLASIA OFPHALANGES AND METACARPALS/METATARSALS, INCLUDED;;ROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH BRACHY-SYN-POLYDACTYLY,INCLUDED	0.000843882	0.05558690990262499
#180700 ROBINOW SYNDROME, AUTOSOMAL DOMINANT; DRS;;ROBINOW DWARFISM;;FETAL FACE SYNDROME;;ACRAL DYSOSTOSIS WITH FACIAL AND GENITAL ABNORMALITIES	0.000843882	0.05558690990262499
LYMPHEDEMA, HEREDITARY, III	0.000843882	0.05558690990262499
CRANIOFRONTONASAL SYNDROME; CFNS	0.000843882	0.05558690990262499
TURNPENNY-FRY SYNDROME; TPFS	0.000843882	0.05558690990262499
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.000843882	0.05558690990262499
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.000843882	0.05558690990262499
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.000843882	0.05558690990262499
MENTAL RETARDATION, X-LINKED 106; MRX106	0.000843882	0.05558690990262499
IMMUNODEFICIENCY 23; IMD23	0.000843882	0.05558690990262499
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.000843882	0.05558690990262499
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.000843882	0.05558690990262499
RITSCHER-SCHINZEL SYNDROME 1	0.000843882	0.05558690990262499
NOONAN SYNDROME 11; NS11	0.000843882	0.05558690990262499
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.000843882	0.05558690990262499
Jawad syndrome	0.000843882	0.05558690990262499
#607454 SPINOCEREBELLAR ATAXIA 21; SCA21	0.000843882	0.05558690990262499
CHROMOSOME 16Q22 DELETION SYNDROME	0.000843882	0.05558690990262499
CHROMOSOME 10q22.3-q23.2 DELETION SYNDROME	0.000843882	0.05558690990262499
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.000843882	0.05558690990262499
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.000843882	0.05558690990262499
OROFACIODIGITAL SYNDROME IX; OFD9	0.000843882	0.05558690990262499
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.000843882	0.05558690990262499
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.000843882	0.05558690990262499
300270 ADRENOMYODYSTROPHY	0.000843882	0.05558690990262499
#613076 MYOPATHY, MITOCHONDRIAL PROGRESSIVE, WITH CONGENITAL CATARACT, HEARINGLOSS, AND DEVELOPMENTAL DELAY;;MYOPATHY WITH CATARACT AND COMBINED RESPIRATORY CHAIN DEFICIENCY;;MITOCHONDRIAL COMPLEX DEFICIENCY, COMBINED	0.000843882	0.05558690990262499
COHEN-GIBSON SYNDROME; COGIS	0.000843882	0.05558690990262499
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.000843882	0.05558690990262499
SECKEL SYNDROME 8; SCKL8	0.000843882	0.05558690990262499
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.000843882	0.05558690990262499
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.000843882	0.05558690990262499
#300257 DANON DISEASE;;VACUOLAR CARDIOMYOPATHY AND MYOPATHY, X-LINKED;;PSEUDOGLYCOGENOSIS II;;ANTOPOL DISEASE;;LYSOSOMAL GLYCOGEN STORAGE DISEASE WITHOUT ACID MALTASE DEFICIENCY,FORMERLY;;GLYCOGEN STORAGE DISEASE IIb; GSD2B, FORMERLY;;GSD IIb, FORMERLY	0.000843882	0.05558690990262499
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.000843882	0.05558690990262499
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.000843882	0.05558690990262499
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.000843882	0.05558690990262499
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.000843882	0.05558690990262499
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.000843882	0.05558690990262499
#614873 PEROXISOME BIOGENESIS DISORDER 7B; PBD7B	0.000843882	0.05558690990262499
#615220 OSTEOGENESIS IMPERFECTA, TYPE XV; OI15;;OI, TYPE XV	0.000843882	0.05558690990262499
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.000843882	0.05558690990262499
#614582 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 9; COXPD9	0.000843882	0.05558690990262499
NAVAJO NEUROHEPATOPATHY	0.000843882	0.05558690990262499
CREE MENTAL RETARDATION SYNDROME	0.000843882	0.05558690990262499
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.000843882	0.05558690990262499
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.000843882	0.05558690990262499
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.000843882	0.05558690990262499
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000843882	0.05558690990262499
#614732 INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIACONGENITA, AND GENITAL ANOMALIES;;IMAGE SYNDROME	0.000843882	0.05558690990262499
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.000843882	0.05558690990262499
TARP SYNDROME; TARPS	0.000843882	0.05558690990262499
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000843882	0.05558690990262499
HYPERMANGANESEMIA WITH DYSTONIA 2	0.000843882	0.05558690990262499
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.000843882	0.05558690990262499
SENIOR-LOKEN SYNDROME 9	0.000843882	0.05558690990262499
FORSYTHE-WAKELING SYNDROME; FWS	0.000843882	0.05558690990262499
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.000843882	0.05558690990262499
JOUBERT SYNDROME 2	0.000843882	0.05558690990262499
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.000843882	0.05558690990262499
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.000843882	0.05558690990262499
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.000843882	0.05558690990262499
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.000843882	0.05558690990262499
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.000843882	0.05558690990262499
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.000843882	0.05558690990262499
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIg; CDG2G	0.000843882	0.05558690990262499
#612714 EXOCRINE PANCREATIC INSUFFICIENCY, DYSERYTHROPOIETIC ANEMIA, AND CALVARIALHYPEROSTOSIS	0.000843882	0.05558690990262499
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.000843882	0.05558690990262499
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.000843882	0.05558690990262499
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.000843882	0.05558690990262499
CHROMOSOME 4q21 DELETION SYNDROME	0.000843882	0.05558690990262499
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.000843882	0.05558690990262499
SAUL-WILSON SYNDROME; SWILS	0.000843882	0.05558690990262499
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.000843882	0.05558690990262499
AL-RAQAD SYNDROME; ARS	0.000843882	0.05558690990262499
THAUVIN-ROBINET-FAIVRE SYNDROME	0.000843882	0.05558690990262499
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.000843882	0.05558690990262499
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.000843882	0.05558690990262499
#615314 CRANIOSYNOSTOSIS 3; CRS3	0.000843882	0.05558690990262499
BARDET-BIEDL SYNDROME 1; BBS1	0.000843882	0.05558690990262499
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.000843882	0.05558690990262499
DYSTONIA 28, CHILDHOOD-ONSET	0.000843882	0.05558690990262499
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.000843882	0.05558690990262499
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.000843882	0.05558690990262499
HYPERTRYPTOPHANEMIA; HYPTRP	0.000843882	0.05558690990262499
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000843882	0.05558690990262499
CHROMOSOME 17q23.1-q23.2 DELETION SYNDROME	0.000843882	0.05558690990262499
DIAPHANOSPONDYLODYSOSTOSIS	0.000843882	0.05558690990262499
JOUBERT SYNDROME 21	0.000843882	0.05558690990262499
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.000843882	0.05558690990262499
PEROXISOME BIOGENESIS DISORDER 10B	0.000843882	0.05558690990262499
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.000843882	0.05558690990262499
NEPHRONOPHTHISIS 11; NPHP11	0.000843882	0.05558690990262499
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.000843882	0.05558690990262499
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000843882	0.05558690990262499
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.000843882	0.05558690990262499
THANATOPHORIC DYSPLASIA, TYPE I	0.000843882	0.05558690990262499
